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ABSTRACT

EXPLORING THE WORLD OF HELIX ASSOCIATION:
DISEASE MECHANISM, BASIC FOLDING AND NOVEL DESIGN
Yao Zhang
William F. DeGrado, Thesis Advisor

Helix association provides an efficient model for studying the fundamental
principles behind protein folding. It also serves as a suitable template for the design of
proteins with novel functions. This thesis begins by investigating the role of
transmembrane helix association in protein folding, where a novel “protein-foldingcentric” viral fusion model has been proposed here to explain the membrane-fusion
process of paramyxovirus. Furthermore, the forces driving membrane helix association,
which determine both affinity and orientation, have been quantitatively studied using a
model membrane peptide MS1. Finally, two examples are discussed that illustrate the
application of helix association in novel protein design. A pH-switchable drug delivery
system for the endosomal escape of biomacromolecular therapeutics has been designed
using the helix-association model. The sequence is designed to form a stable watersoluble helix bundle at pH 7.4 and to insert in membrane at lower pH to promote
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endosomal escape. The most successful sequence shows selective release for
biomacromolecule (ATP and miRNA) at lower pH (pH 5.4). The assembly of the
designed peptide has been studied in aqueous buffer, detergent micelle and model lipid
bilayer using the most successful sequence. Also, the paradigm of helix association has
been applied to the design of a membrane metalloprotein, which can serve as a template
for further design of membrane metalloenzymes. In summary, the work in this thesis has
established an efficient model for helix association that can be used to solve problems in
both basic and applied research.
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1 Chapter 1: Introduction: The fundamentals of protein
folding and the model of helix association

1.1

The significance of protein folding
Proteins carry out vital functions in every living creature.1 The proper folding of

proteins into their specific three-dimensional structures is the only way that the correct
function can be achieved.1 The ability to interpret the relationship between the primary
sequence of protein and its folding will not only help understand the pathology of protein
misfolding-related diseases such as Alzheimer‟s,2 cystic fibrosis,3 and prions disease;4 but
also create new functions such as novel enzymes, biomaterials and delivery agents. After
decades of effort, protein folding is subject to the attentions of multiple disciplines, such
as biology, chemistry, physics, mathematics, and engineering; and is one of the most
fundamental processes studied by science.

While the mechanism of protein folding is complicated, the final folded status,
including secondary, tertiary and quaternary structure, is simply determined by the
primary sequence of a protein.5 Nevertheless, the process that translates from sequence to
the final folded structure is still mysterious. One strategy to investigate this mystery is to
identify the sequence motif that determines specific interactions. With the golden rules
identified, we can predict unknown protein structures/functions, also design novel
protein-based functions, which are two major goals in the field of protein folding research.
1

1.2

The impediments to studying protein folding
The major challenge in the field of protein folding originates from the complexity

of the systems that proteins are involved in. The major contributors to this complexity
would be folding hierarchy, environmental factors, and folding dynamics.

Folding takes multiple steps. It has been proposed that the sequence first searches
into a specific secondary structures, such as alpha-helix, beta-sheet, etc.6 Then the single
chain further forms tertiary structures driven by forces such as local hydrophobic
interaction, hydrogen-bond formation and ligand binding.7 Sometimes in order to obtain a
more advanced function, a group of tertiary structures need to interact with each other
and further form quaternary structures.7

Secondly, the sequence of amino acids alone usually does not completely
determine the folding pathway, although it determines the final fold. Environmental
factors such as pH,8 ligand binding,9 thermal changes,10 energy transfer,11 etc., frequently
play key roles which triggers/assists the folding and also add to the variables in the
equation of folding.

A third hurdle to understanding protein folding comes from the dynamics of the
folding process itself. Regardless of reaching equilibrium or not, the system usually
2

involves transitions among multiple components in a dynamic way.12 Taking the
dynamics into consideration, the system becomes even more complex and mysterious.

Facing the complexity of the protein folding systems, a simplified model is called
for, which should allow us to study the key problems in a detailed manner in a
manageable system and also serve as a scaffold to design more advanced systems.

1.3

The helix-association-based model for studying protein folding
Helix association is the major part of the model of peptide interaction. Statistics

suggests that the predominant structural motif in proteins is alpha-helix in both aqueous
and membrane systems.7 The association of helices is a major part of protein folding and
is thermodynamically linked to protein folding. Helix association has been widely used as
a model to study protein folding because helix association sufficiently represents the key
steps for protein folding in most cases and it also significantly simplifies the system.

In terms of sufficient representatives, successful examples of helix association
have been developed in the field of disease mechanism exploration, such as the six-helix
coiled coil in HIV gp41,13 the tetramer M2 proton transporter in influenza virus,14 and the
heterotetramer in SNARE complex.15 Most importantly, inhibitors designed upon these
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segment has successfully blocked folding,16 supporting their uses as sufficient
representatives.

Helix association model is also simplified by the relatively short length of the
studied peptides. Compared to proteins with more than a few hundred residues, a 20-50
residue peptide (helix) is often relatively easier in its synthesis, purification and assay
development, which allows more advanced experimental study. This short length also
saves cost for computational modeling/simulation, both in terms of coding time and
calculation circles. Altogether, peptides (helix) have been considered as a practical model
for studying protein folding.

1.4

The coiled-coil model
Coiled-coil helix interactions are one of the most studied types of helix

interactions. Coiled coils represent a ubiquitous and important structural motif in helices
and also in proteins, with 10% estimated population in proteins. 17

In coiled coils two to seven alpha helices coil with each other into a strand of
rope.18 Usually this super-twist is left-handed. Because of the geometry of the left-handed
coiled coil, the orientation of the amino acids repeats every seven residues with respect to
the protein interface. That is why coiled coils are characterized by a so called heptad
4

repeat in their primary sequences (abcdefg)n,19,

20

in which the a and d positions are

presented at the interface and play essential roles for bringing helix association (Figure 1).
A

B

Figure 1.1 A schematic coiled coil heptad repeat for a parallel dimer (A) and a parallel
heptamer (B) The schematic map is made via program DrawCoil 1.0, developed by Dr.
Gevorg Grigoryan (http://www.gevorggrigoryan.com/drawcoil/).

One of the most studied left-handed coiled coils is the water-soluble parallel
dimer GCN4-p1, the coiled-coil domain of the yeast transcription activator GCN4.21
Mutations in GCN4-p1 can derive coiled coil variants that are trimers or tetramers,22, 23
and parallel or anti-parallel,24 which will be discussed later in the introduction. Recently a
de novo designed left-handed parallel seven-helix coiled coil has been characterized with
the 1.25 Å crystal structure, which reveals a large tubular channel in the interior.25
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Like left handed coiled-coils, right-handed coiled coils have also been discussed
in both natural and designed system, such as a parallel tetramer with 11-residue repeats
from the surface layer of the protein tetrabrachion26 and a parallel tetramer with 15residue repeats from human vasodilator-stimulated phosphoprotein (VASP).27 These
right-handed coiled coils represent the versatility of the coiled coil and play important
roles in biological functions and design purposes.

Coiled coils have been extensively studied in the past few decades. The
accumulated information and regularity of from coiled coil make them a preferred model
system for study/design of helix association. In the following part of the introduction,
case studies will illustrate the application of the coiled-coil model in research of both
aqueous (water-soluble) system and membrane system.

1.5

Case study of GCN4-p1: the folding in an aqueous system
GCN4-p1 is a parallel, left-handed water-soluble homodimer. Crystal structure

suggests that GCN4-p1 adopts a coiled-coil conformation, with the side chains in the
interface packing into the classical “knob-into-holes” model.28 As seen in the sequence
of the primary coiled coil region, four leucines are aligned as a twisted ladder along the a
position of the helix, forming the canonical “leucine zipper” and promoting dimerization
(Figure 1.2). This leucine zipper echoes nicely with the previous research that
hydrophobic interaction is the driving force for water-soluble protein folding. 29, 30
6

A.

Peptide

abcdefg abcdefg abcdefg abcdefg abcdefg

GCN4-P1

MKQLEDK VEELLSK NYHLENE VARLKKL VGER

B.

Figure 1.2 The sequence and sketch map of heptad repeat for GCN4-p1. The schematic
map is made via program DrawCoil 1.0

Not limited in GCN4-p1, on average 80% of the a and d position in natural watersoluble coiled coils are occupied by apolar residues.31 Also, inserting unnatural amino
acids with stronger hydrophobicity, such as trifluoroleucine or trifluorovaline, leads to
higher stability for coiled coils.32, 33
Hydrophobic interactions not only affect coiled coils‟ stability, but also determine
their specificity. A series of mutational studies have been done with GCN4-p1. The
coiled coil stays as a dimer with “I” and “L” in a and d positions respectively; it becomes
a trimer with “I” in both a and d positions; and it is turned into tetramer with “L” and “I”
in a and d positions respectively.22, 23
7

Hydrogen bonding is another major force driving the folding of coiled coils in
aqueous systems. The polar residues in the core positions play a key role in determining
specificity, supported by the fact that polar residues comprise 20% population of all the
residues in the a and d positions of natural coiled coils.31 If the asparagine in the a
position in GCN4-p1 is altered into a valine, the stability of the coiled increases due to
the increase in hydrophobic packing, however, the predominance of dimeric form
disappears.34

Ionic interaction between the e and g´, as well as e´ and g (Figure 1.2B) , also
plays important roles in determining the stability and specificity for left-handed coiled
coils, which are defined as the canonical i to i+5 salt bridge in heptad-repeat systems.20
As shown in Figure 1.2, in GCN4-p1 the glutamic acid and lysine, in the e and g´, as well
as e´ and g positions respectively, form a favorable salt bridge and stabilize the
homodimer. The formation of a salt bridge highly depends on sequence, space, geometric
preferences and environment factors.35 For example, the salt bridge contributes about 1 to
2 kJ/mol to coiled coil stability, depending on salt concentration.36-39

Interestingly, replacing the charged residue in e or g positions with apolar
residues results in an anti-parallel tetramer,40 while replacing both the charged residues in
e and g positions with the small apolar residue alanine results in a parallel seven helixcoiled coil.25 This discloses the importance of packing at the e and g positions for water8

soluble coiled coils, which apparently play very interesting roles in determining the
specificity of coiled coil and deserves further exploration.

Specificity regarding oligomerization has been discussed above. Many
investigations into the specificity of interaction orientation have also been done in the
past few decades. Since the majority of coiled coils appear to form parallel relative helix
alignments in the earliest studies, the design of anti-parallel coiled coils or helix bundles
has become an interesting current topic.24 The first reported de novo designed antiparallel coiled coil was restrained by an interior disulfide bond.41, 42 A major advance was
when glutamic acid and lysine were engineered to interact only when the helices adopt an
anti-parallel orientation in a heterodimer;28 and an asparagine pair in the adjacent helices
was engineered to interact only when the helices adopt anti-parallel manner in
homodimer.43

The successful design of anti-parallel trimer coiled coils44,

45

and anti-parallel

three-helix bundle46 are mainly based on the modification of the homotrimeric parallel
coiled coil by the manipulating Coulomb interactions from charged residues. Also,
tryptophan residues have been proposed to contribute to the formation of an antiparallel
trimer since three indole sidechains would be poorly accommodated in a parallel coil.44, 47
Moreover, effort has been made in modifying interactions between b and e position, as
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well as g and c positions, as these interactions significantly contribute to the stabilization
of anti-parallel four stranded coiled coil.48

1.6

The application of coiled coil-based design in aqueous systems
In recent decades, coiled-coil-based design has succeeded in diverse fields, thanks

to the gradually accumulated knowledge of sequence-determined stability and specificity.
Here I will highlight a few examples in aqueous systems.

Biofuel cell cathodes have been designed based on a coiled coil dimer, taking
advantage of a coiled-coil‟s physical self-assembly functionality.49 An antibody screening
assay against HIV-1 has been designed based on the coiled-coil region of the transient
viral entry intermediate (the prehairpin intermediate) formed by the HIV-1 gp41
protein.50 A vaccine has been designed for prototypical Severe Acute Respiratory
Syndrome (SARS), the design of which is based on the C-terminal coiled coil of the
virus‟ spike protein.51 A novel protein fiber has been designed based on a leucine zipper
coiled coil. This self-assembled coiled coil can super assemble into a fiber that measure
about 45 nm across52 and could serve as a perfect scaffold for future tissue engineering.

Computational calculations, modeling and simulation have boomed in the field of
rational design. Nowadays scientists not only use computational programming to pack the
10

designed structure in order to achieve the sequence with the most stable target structure,53,
54

but also utilize negative design to improve final specificity.55

Undoubtedly, coiled coils provide efficient scaffolds for future design and present
great potential for diverse applications.

1.7

Understanding membrane protein folding with coiled-coil-based design
As remarkable as the contribution the coiled-coil-based model has made to the

aqueous system, it also has had great importance in the research of membrane protein
systems.

It is predicated that about 30% of all the genes encode for membrane proteins and
60% of drugs in current market target membrane proteins.56 However, only 1% of
structures in PDB database correspond to membrane proteins. The lack of knowledge
about membrane proteins is mainly because of the difficulties associated with the relevant
studies. From an experimental point of view, first of all most membrane proteins are hard
to express, synthesize and purify compared to water-soluble proteins due to their high
hydrophobicity. Secondly, membrane proteins have to be solubilized in the lipid bilayer
or detergent during studies, thus some established assays in water-soluble systems can‟t
be applied to the membrane target. Moreover, it is hard to find an assay which can create
11

a detectable thermodynamically reversible equilibrium for membrane protein folding.
Computational modeling requires simulation of the lipid or detergent environment, which
creates challenges in molecular dynamics simulations.

Despite the difficulties of working with membrane proteins, significant progress
has been made in the membrane field in the past decade. There are two major classes of
structural motifs in membrane proteins: all-beta sheets and all-alpha helices. The proteins
in cytoplasmic membranes are essentially all in the all-alpha class, whereas the outer
membranes of bacteria and mitochondria also are rich in all-beta. However, most
pharmacologically relevant membrane proteins are all-alpha helices therefore the
majority of work on membrane protein has focused on the transmembrane (TM) helix.57

In a well-accepted model, membrane helix association involves two kinetically
separate steps: In the first step the TM helical region is inserted into lipid bilayer; in the
second step the TM helices interact with each other and form bundles57, 58. This thesis
will focus on the second step and explore the folding mechanism for membrane helix
association and relative designs.

Where the issue of folding is concerned, it is always required to identify an
unfolded state and a folded state in the beginning of study. In our helix-association model,
12

the unfolded state would be the single helix which retains the helical secondary structure;
and the folded state is the associated helix bundle.59 Mirroring the trajectory of watersoluble systems, the coiled coil model has been widely used in understanding the driving
force for membrane helix association and helix-association-based membrane protein
design. This thesis will highlight the successful design and characterization of the model
peptide MS1, a putative membrane coiled coil.

1.8

Case study of MS1: folding in micelles and bilayers
MS1 is designed based on the classic water-soluble coiled coil GCN4-p1. The

design maintains the core residues in a and d positions of GCN4-1:60 “V” “N” “V” “V”
in consecutive putative a positions and “L” in all the putative d positions (Figure 1.3).
Fluorescence and sedimentation analytical ultracentrifugation assays suggest that MS1
adopts an equilibrium of a monomer-dimer-trimer in detergent micelle N-tetradecyl-N,N
dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine). The maintained asparagine has
been shown to play a crucial role in the self-association of MS1: the mutation of
asparagine into valine (N14V) eliminates the ability to oligomerize.60 Mutation of
asparagine into other polar residues with two polar atoms such as glutamine, aspartic acid
and glutamic acid, retains the ability to form stable trimers, while the mutation of
asparagine into polar residues with one polar atom such as serine and threonine, results in
a much weaker tendency to associate.61 It is proposed that the inter-molecular hydrogen-
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bond network formed by the asparagine is the major driving forces for the helixtrimerization in MS1. 62

With MS1, the role of hydrophobic effect in membrane helix association has also
been probed. The mutation L10A (Figure 1.3) probes how hydrophobicity in putative d
positions affects that association of membrane helices. Interestingly this alteration does
not change the oligomerization state. Moreover, the variant forms significantly tighter
trimers than the wild type (by -0.5 kCal/mol monomer), which suggests that hydrophobic
interactions are not the major driving forces for membrane helix association. Instead,
small residues are preferred in the helical interface60, 63, which will be further discussed in
Chapter 3.

Figure 1.3 The sequence of MS1 and variants

14

A parallel project carried out at the same time also emphasizes the importance of
polar residue in membrane helix association. The TM part of this parallel design is also
based on GCN-p1, which maintains the residues in the putative a position (VNVV) and
replaced the rest of the residues with leucine. Thermodynamic studies with this design
suggest that helix association is driven by the polar asparagines at the putative a position,
independent of the rest of the hydrophobic leucine sequence in both detergent micelles
and biological membranes.64

The importance of polar residues in membrane protein folding also echoes the fact
that mutations of the polar residues in membrane proteins are usually the most common
disease initiators for membrane protein related diseases.65, 66 Interestingly, this important
driving force in some cases is relatively modest. Using bacteriorhodopsin as the target
systems, double-mutation cycle analysis suggests that the average contribution of the
eight hydrogen-bonding interactions in bacteriorhodopsin is only about 0.6 kcal/mol. The
authors proposes that this important while modest hydrogen-bonding might result from
the geometry constrains or evolutionary pressures.67, 68

1.9

Membrane structural motifs
As the exploration of membrane protein extends, structural motifs/rules about

membrane protein folding have gradually been revealed. Discovered in glycophorin A,6974

the GxxxG motif has been shown to drive membrane helix dimerization by promoting

van der Waals interaction with an ideal geometric fit and weak Cα-H hydrogen-bonding.
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Extensive mutagenesis studies suggest that the motif LIxxGVxxGVxxT is crucial for the
dimerization of glycophorin A.69, 70 Further statistics suggests that this role of glycine
can also be extended to other small residues such as alanine and serine. Therefore this
motif has been updated to the [Sm]xxx[Sm] motif that drives TM helix association,
where “[Sm]” here refers to small apolar residues.74

As more crystallographic structures of membrane proteins are deposited to the
PDB library, the analysis of the membrane helix interactions have been categorized into
two groups.75 For the right-handed membrane helix interactions, GxxxG or [Sm]xxx[Sm]
is the most popular structural motif. For the left-handed membrane helix interactions,
small residues, such as glycine or serine, repeating in every seven residues, are
commonly seen in the packing interface. Heptad repeats of serine, which is called a serine
zipper, have been used to design anion channel peptide76 and an anti-parallel membrane
helix bundle.77 Also, hydrogen bonds via polar residues are frequently found to mediate
the association in left-handed membrane helices.78

1.10 The application of sequence-based protein folding studies
The ultimate goal of sequence-based folding studies is to predict the protein
structure based on the primary sequence, and to design protein sequence which can obtain
specific functions.
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The accumulated understanding of membrane protein folding provides support for
structural prediction of membrane proteins.79-81 The knowledge of first principles and
prediction has also promoted the rational design of functional membrane proteins, such
as activator

82

for platelet integrins, a drug delivery agent,83 and a diporphyrin-binding

TM electron transfer protein.84 In both prediction and design, computational calculation
and modeling have played significant roles. Adding explicit terms and modeling realistic
membrane phases has significantly increased the success rates of the designs.80, 84 More
detailed examples will be discussed in the following chapters.

1.11 The exploration of helix association in both aqueous and membrane systems
This thesis focuses on the application of helix association in both fundamental and
applied research, such as: discovering the role of helix interaction in diseases, especially
viral fusion/entry (Chapter 2), exploring the driving forces for membrane helix
association (Chapter 3), designing a pH-switchable helix-association based drug delivery
agent (Chapter 4), and designing a membrane metal-binding four-helix bundle (Chapter
5).
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2 Chapter 2 Transmembrane Orientation and Possible Role
of the Fusogenic Peptide from PIV5 Virus in Promoting
Fusion

2.1

Abstract
Membrane fusion is required for diverse biological functions ranging from viral

infection to neurotransmitter release. Fusogenic proteins increase the intrinsically slow
rate of fusion by coupling energetically downhill conformational changes of the protein
to kinetically unfavorable fusion of the membrane-phospholipid bilayers. Class I viral
fusogenic proteins have an N-terminal hydrophobic fusion peptide (FP) domain,
important for interaction with the target membrane, plus a C-terminal transmembrane (Cterm-TM) helical membrane anchor. The role of the water-soluble regions of fusogenic
proteins has been extensively studied, but the contributions of the membrane-interacting
FP and C-term-TM peptides are less well characterized. Typically, FPs are thought to
bind to membranes at an angle that allows helix penetration but not traversal of the lipid
bilayer. Here we show that the FP from the paramyxovirus PIV5 fusogenic protein, F,
forms an N-terminal TM helix, which self-associates into a hexameric bundle. This FP
also interacts strongly with the C-term-TM helix. Thus, the fusogenic F protein resembles
SNARE proteins involved in vesicle fusion by having water-soluble coiled-coils that
zipper during fusion and TM helices in both membranes. By analogy to mechanosensitive
channels, the force associated with zippering of the water-soluble coiled coil domain is
expected to lead to tilting of the FP helices, promoting interaction with the C-term-TM
helices. The energetically unfavorable dehydration of lipid headgroups of opposing
18

bilayers is compensated by thermodynamically favorable interactions between the FP and
C-term-TM helices as the coiled-coils zipper into the membrane phase, leading to a pore
lined by both lipid and protein.
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2.2

Introduction
The basic mechanisms of viral membrane fusion have been studied extensively,

but major gaps remain in our understanding of the relative roles of lipidic intermediates
and viral fusogenic proteins in lowering the energy barrier for the overall process

85-88

.

The most common mechanistic hypothesis concerning enveloped viral fusion is that
fusogenic proteins primarily serve to bring the target cell and viral membranes into
proximity. Fusion occurs in a multi-step process, in which the virus first binds to a
specific receptor; this event and/or other environmental cues then cause a conformational
change in the protein, leading to a metastable state with an exposed hydrophobic fusion
peptide (FP) that binds to the target membrane. Once engaged with the bilayer a second
energetically favorable conformational change in the fusogenic protein then exerts a force
pulling the FP towards the viral membrane, in effect reeling the host and viral membranes
together.

The conformational changes involved in the water-soluble portions of viral
fusogenic proteins have been largely elucidated, but the roles of the membrane-binding
FP and the C-terminal transmembrane (C-term-TM) anchor are less clear. After the
crystal structure of the pre-fusogenic form of influenza hemagglutinin (HA) was solved 89,
experimental studies suggested that its FP inserted into the bilayer

90

. The FP helix was

thought to bind sufficiently deeply to act as a hydrophobic wedge that not only served as
an anchor but also destabilized the bilayer and facilitated fusion. Many biochemical,
biophysical and mutagenesis studies on the fusion proteins of the influenza virus, HIV
20

and other viruses are consistent with, and have added considerable detail to, this initial
suggestion

91-118

. However, a number of intriguing findings suggest that the FPs and C-

term-TM helices might play additional, more specific, roles in bilayer fusion than mere
membrane binding and disruption.

Surprisingly subtle mutations in the C-term-TM sequence of fusogenic proteins
can be quite deleterious to their ability to induce fusion, while retaining normal
processing and the ability to change conformations

119-122

. Also, replacing C-term-TM

helices of fusogenic proteins with lipid anchors results in a loss of fusion

123-126

and,

surprisingly, FP sequences often show greater conservation than might be expected from
the functional requirements for membrane binding

127

. Moreover, the very strong

conservation of polar and small residues at regularly spaced intervals as found in
GXXXG 70, 74, 128, glycine zippers 129, and GAS motifs 75 (Table 2.1), is intriguing. These
patterns are known to stabilize TM helix association and also figure in the helix-helix
packing of proteins that undergo large-scale conformational changes in response to
lipidic environment, such as in mechanosensitive (MS) channels 130.

Thus, we investigated whether FPs might adopt TM helical rather than surface
orientations, and how this might relate to their mechanisms of action. If indeed FPs adopt
a TM orientation, then one might envision a mechanism akin to SNARE proteins

131-134

,

in which both the target and vesicular proteins have TM helices that associate as
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membrane fusion progresses. Accordingly, we investigate herein a class I fusogenic
protein, F, from parainfluenza virus 5 (PIV5), which, like influenza virus HA and HIV
gp41, has an N-terminal FP in the mature, cleaved protein

87

. High-resolution structures

are available for both the pre- and post-fusion forms of the ectodomain of the F protein
135-137

, and the structure and function of its C-term-TM domain has been extensively

investigated by scanning mutagenesis and Cys crosslinking
suggests that it also forms a TM helix

56

138

. The sequence of the FP

. Moreover, it has a single polar Gln residue, a

residue known to promote helix-helix interactions in membranes

61

, plus glycine and

alanine residues in a heptad repeat pattern (Figure 2.1B), known to stabilize TM helixhelix assembly 59, 78, 139 and pore formation 129. The sequence variability of the FP across
homologous viruses shows a heptad repeat in phase with the heptad repeat of the long
water-soluble coiled-coil, which directly follows it (Figure 2.1C, 1D), interrupted only by
a highly conserved region (residues 112-117) that is constrained by packing in the prefusion trimer 136, 140. Consistent with this, the postfusion structure of PIV5 135 showed that
the C-terminus of the fusion peptide is helical. Here, we show that this FP adopts a TM
orientation in phospholipid membranes, specifically oligomerizing into a homohexameric
bundle (6HB) and it also associates with the C-term-TM domain in micelles.
Computational studies suggest that conformational changes involving zippering of the
water-soluble coiled-coil in the ectodomain drive changes in helix-crossing angles that
may lead to an initial heteromeric contact or “pin-prick” between the FP and the C-termTM leading to a fusion pore possibly lined by both protein and lipid.
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Figure 2.1 Sequence conservation suggests a continuous helix including heptad repeat A
(HRA) and the fusion peptide. (A) Postfusion crystal structure of the soluble domain of
closely related hPIV3 virus F protein 135. Shown in magenta is HRA. Below HRA, in the
postfusion membrane, is the predicted location of the fusion peptide. (B) Heptad repeat of
the fusion peptide and HRA. The beginning of the crystallographic resolved region of
HRA is shown in magenta. Heptad repeats of small residues in the fusion peptide are
boxed. (C) Sequence entropy of the fusion peptide and HRA can be fit to a single
sinusoidal function with period of 3.47 ± 0.02 residues/turn (r = 0.51). (D) Sequence
entropy of the fusion peptide alone can be fit to a single sinusoidal function with a period
of 3.51 ± 0.08 residues/turn (r = 0.59).
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Table 2.1 Conservation of small residues (Ala, Gly) within four virus families.
Each family uses a type I fusion protein with an N-terminal fusion peptide. Small
residues are shown in bold. Note that even distantly related viruses often conserve the
position of small residues.

Orthomyxoviridae:
Influenza A H1

GLFGAIAGFIEGGWTGMIDGWYG

Influenza A H3

GLFGAIAGFIENGWEGMIDGWYG

Influenza A H5

GLFGAIAGFIEGGWQGMVDGWYG

Influenza B

GFFGAIAGFLEGGWEGMIAGWHG

Influenza C

IFGIDDLIIGVLFVAIVETGIGGYLLGS

Retroviridae:
HIV-1, Group M, Clade A

AIGMGAFFLGFLGAAGSTMGAASITLTVQA

HIV-1, Group M, Clade B

AVGIGALFLGFLGAAGSTMGAASMTLTVQA

HIV-1, Group M, Clade C

AVGIGAVFLGFLGAAGSTMGAASITLTVQV

HIV-1, Group O

AVGLGMLFLGVLSAAGSTMGAAATTLAVQT

HIV-1, Group N

AAFGLGALFLGFLGAAGSTMGAASITLTVQA

HIV-2

GVFVLGFLGFLATAGSAMGAASLTLSAQS

SIV, rhesus monkey

GVFVLGFLGFLATAGSAMGAASLTLTAQS

SIV, chimpanzee

AAFGLGALFLGFLGAAGSTMGAAAVTLTVQA
24

Human T-cell leukemia virus AVPVAVWLVSALAMGAGVAGGITGSMSLASG

Paramyxoviridae:
Human parainfluenza virus 1

FFGAVIGTIALGVATAAQITAGIALA

Human parainfluenza virus 3

FFGGVIGTIALGVATSAQITAAVALV

Simian parainfluenza virus 5

FAGVVIGLAALGVATAAQVTAAVALV

Measles

FAGVVLAGAALGVATAAQITAGIAL

Sendai virus

FFGAVIGTIALGVATSAQITAGIALA

Nipah virus

LAGVIMAGVAIGIATAAQITAGVALY

Newcastle virus

FIGAIIGSVALGVATAAQITAASALI

Respiratory syncytial virus

FLGFLLGVGSAIASGVAVS

Arenaviridae:
Lassa fever

GTFTWTLSDSEGKDTPGGYCLT

Lymphocytic choriomeningitis

GTFTWTLSDSSGVENPGGYCLT

Junin arenavirus

AFFSWSLTDSSGKDTPGGYCL

Machupo virus

AFFSWSLTDSSGKDMPGGYCL

Guanarito virus

AFFSWSLSDPKGNDMPGGYCL

Sabia virus

GIFSWTITDAVGNDMPGGYCL
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2.3 Results
Association of Fusion and C-term-TM Peptides in Detergent Micelles
Analytical ultracentrifugation (AUC) of the FP from PIV5 F protein in
phospholipid micelles reveals cooperatively assembly into hexamers (Figure 2.2). The FP
was dissolved in dodecylphosphocholine (DPC) micelles, and the density of the solution
was adjusted to precisely match that of the DPC detergent

82

so that only the protein

component contributes to the sedimentation equilibrium. Three samples prepared at
differing peptide-to-detergent ratios were each centrifuged at four to five rotor speeds,
respectively, for the wild-type and mutant Q120A. The data were then globally analyzed
to extract the number of peptides per oligomer as well as the free energy of association 82,
139, 141

. The data conform very well to tightly associating and fully cooperative monomer-

hexamer equilibrium (Figure 2.3). The addition of lower-order intermediate states failed
to improve the quality of the fit, indicating that the association was highly cooperative
and specific for the formation of hexamers relative to other possible association states.

The mutant Q120A also forms hexamers (Figure 2.2C, 2D, 3B), but its
association is weaker than that of the wild-type peptide by 13.4 kcal/mol of hexamer, or
2.2 kcal/mol of monomer. Glutamine (Gln) is well known to stabilize the association of
TM helices

61

and the magnitude of the effect is similar. Thus, it is likely that the Gln

helps stabilize TM helix association within the structure, although this residue is not
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absolutely essential for forming the 6HB. Q120 is strongly conserved in related viruses
(Table 2.1) and is a promising target for future studies using reverse-engineered viruses.

While the C-term-TM domain has been shown to associate in the full-length
protein

138

, the C-term-TM peptide alone does not associate in DPC micelles (Figure

2.4A). However, when unlabelled wild-type FP is introduced at a 1:1 ratio, the C-termTM-peptide strongly associates (Figure 2.4B), perhaps adopting a structure relevant for
the postfusion state. Analysis of the sedimentation curves indicates that the TM peptide
self-associates with the FP at least 20-fold less tightly than the corresponding heteromeric
interaction with the C-term-TM peptide.
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Figure 2.2 Analytical ultracentrifugation of fusion peptide wild-type (A, B) and mutant
Q120A (C, D). Single species fitting of wild-type (A) and mutant Q120A (C) PIV5
fusion peptide suggests both associate as hexamers. The top of each panel shows the
residuals of single species fitting. The species weight fraction is shown for wild-type (B)
and mutant Q120A (D), indicating that hexamer is the dominant species composition for
the wild-type, while oligomerization of the mutant Q120A requires significantly higher
mole fractions.
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Figure 2.3 Sedimentation equilibrium analysis of the wild-type (A) and mutant Q120A
(B) fusion peptides in DPC micelles. The absorbance was measured at 280 nm. The data
was fitted as a monomer-hexamer equilibrium, resulting in a pKdissociation of 20.1 for the
wild-type and a pKdissociation of 10.2 for the mutant Q120A. The top of each panel shows
the residuals of the fit. In this data analysis the concentration of peptide is the mole ratio
of peptide/detergent and therefore is unitless.
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Figure 2.4 Analytical ultracentrifugation of C-term-TM peptide alone (A) and C-termTM peptide-fusion peptide mixture (B). No significant curvature has been observed in
AUC data of TM peptide alone (A) suggesting that C-term-TM peptide does not selfassociate under these conditions. Single species fitting for a 1:1 mixture of C-term-TM
peptide and fusion peptide (using the original sequence without a Trp label) suggests a
strong interaction between these peptides.
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Fusion Peptides Adopt a TM Orientation in Lipid Bilayers
The secondary structure and orientation of the wild-type and mutant FP in
micelles and deuterium oxide (D2O) hydrated bilayers were evaluated using circular
dichroism (CD) and attenuated total reflection IR spectroscopy (ATR-IR), respectively.
The CD spectra of both peptides in DPC micelles are typical of alpha-helix (Figure 2.5)
indicating that the association observed by AUC corresponded to the formation of helical
bundles. The IR spectra in the amide I region of the FPs shows a single, sharp peak at
1656 cm-1, indicative of a dehydrated helical conformation

142

in bilayers (Figure 2.6 A,

B). The dichroic ratio for parallel versus perpendicularly polarized light was 3.2 and 3.6
for the wild-type and mutant, respectively. These values correspond to an orientation of
approximately 29º and 22ºrelative to the membrane normal

143, 144

, assuming the entire

peptide is fully helical and the bilayers are well ordered. Deviation from helical geometry
or disorder of the bilayer would result in somewhat lower dichroic ratios. In this case, the
true angles would be even closer to parallel to the bilayer normal. Thus, both peptides
have a strong preference to adopt a TM orientation relative to other possibilities in which
the helix was either randomly oriented or oriented parallel to the membrane surface.
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Figure 2.5 CD spectra of fusion peptide wild-type (A) and mutant Q120A (B). The
spectra show that both wild-type and Q120A are predominantly α-helical at a
peptide:DPC ratio of 1/200.
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Figure 2.6 Attenuated total reflection IR spectroscopy (ATR-IR) of fusion peptide wildtype (A) and mutant Q120A (B) in phopholipid (POPC) bilayers. The sharp peak at 1656
cm-1 is indicative of alpha helical secondary structure. The TM orientation is
demonstrated by the much greater intensity of the 1656 cm-1 amide I bond for parallel (0º)
versus perpendicular (90º) polarized incident light (relative to the membrane normal).
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Computational Modeling of the 6HB
To model the FP 6HB, the possible structural space was systematically sampled
and scored using a protocol akin to the conformational search of Brunger, Arkin and
coworkers

145

. The strong heptad repeat (Figure 2.1C, D) is indicative of a left-handed

helical bundle. A left-handed bundle also would be consistent with a continuous helical
structure beginning in the soluble heptad repeat A (HRA) and continuing directly to
fusion peptide, as the conservation pattern suggests (Figure 2.1C). Moreover, the nature
of viral fusion, with asymmetric insertion of peptides into the target membrane, suggests
that the FPs comprising the 6HB should adopt a parallel orientation. Symmetric, parallel
coiled-coils can be described by a limited number of variables

146

. Three of these: α-

helical phase (φ), pitch angle (α), and superhelical radius (R) were allowed to vary and
were sampled systematically in search of optimal coiled-coil structures.

For each

structure, optimal rotamers were selected and the structure then minimized.

Each

structure was scored using the CHARMM energy function in an implicit membrane
environment 147, 148 to select candidate models.

The energy of a particular 6HB conformation depends primarily on the phase, φ.
Multiple energy minima are observed as the helices are rotated (Figure 2.7A). Five lefthanded structures were selected, corresponding to the lowest energy basins, for further
refinement using molecular dynamics (MD) simulations in an explicit fully hydrated lipid
bilayer. The lowest predicted energy for an antiparallel orientation 6HB was selected as a
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negative control. It was less stable in MD simulations than the low-energy parallel
models and was not further pursued (Figure 2.7, 2.8).

MD simulations on the five parallel 6HB structures (labeled according to their
phases, φ = 40º, 43º, 88º, 196º, and 300º, respectively) show that the orientation of the
Gln side chain is crucial for 6HB stability. Two closely related structures, φ = 40º and 43º
(Cα RMSD = 1.6 Å), place the Gln in a d position within the coiled-coil while the phase
88º structure places the Gln in a position. The remaining two structures have Gln facing
the lipid (phase 196º and 300º), are much less stable than the interior-facing ones (Figure
2.7B, 8), and rapidly depart from their initial structures (as measured by Cα RMSD),
while structures with an interior Gln are stable near the initial structure for 50 ns of MD
simulation.

Of the interior facing Gln structures, the phase 40º and 43º models are most stable
during the MD simulation and best maintain a symmetric coiled-coil structure (Figure
2.8). These models form a highly stable hydrogen bond network in the interior of the
6HB coiled-coil (Figure 2.9A), consistent with the important role Gln plays in
oligomerization (Figure 2.2). The periodically conserved small residues of the FP are
found at the helix interface in this model. Of note is the penetration of water into the core
of the 6HB from the viral side of the membrane (Figure 2.9B). It is possible that the
formation of the FP 6HB structure may reduce the barrier to fusion by initiating
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formation of a nucleus for expansion into the later, much larger fusion pore. In the less
stable models (phases 88º, 196º, and 300º) the water distribution is not stable due to
either a less favorable arrangement of the Gln side chains (88º) or to their location outside
the pore (196º and 300º) (Figure 2.10).

The most stable 6HB (φ=40°) structure was then used to compute an FTIR
dichroism ratio following the method of Arkin and coworkers 149, 150 where the individual
residue dipoles are combined. The computed dichroism ratio is 2.95 ± 0.07 (mean and
standard deviation over the MD simulation), in good agreement with the experimental
value (Figure 2.6).
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Figure 2.7 Computational prediction of the hexameric helical bundle. (A) Heat map
shows predicted energies of coiled-coil models with different radii and phases. Regions
in black are predicted to be more energetically favorable. (B) Backbone atom RMSD of
five coiled-coil models selected from (A) and one antiparallel model generated using an
analogous procedure. Parallel models are labeled according to their phase angle.
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Figure 2.8 Final structures of the MD simulations of different hexamer models and coiled
coil parameters as a function of time.

(A-F) Final backbone structures in cartoon

representations of five parallel models of the hexamers corresponding to the phase angles,
φ, of 40º (A), 43º (B), 88º (C), 192º (D), 300º (E), and of the antiparallel model (F). The
heavy atoms of the Gln120 side chains are drawn in blue. (G-L) Coiled coil parameters
as a function of time of the six models, in the same order as in (A-F); the deviations from
the initial values of the pitch angle α and of the phase angle φ (Δα and Δφ) are plotted in
green and red, respectively; the deviation of the radius (Δr) is plotted in blue.
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Figure 2.9 Computational model of the PIV5 F fusion peptide hexameric bundle. (A) The
Q120 residues form hydrogen bonds with one another as well as waters on the interior.
(B) Side view shows the bundle oriented with the N-terminal end (which presumably
faces the cellular interior) up. Water is shown in blue. Not shown for clarity are the
phospholipids as well as one helix closest to the viewer.
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Figure 2.10 Density of oxygen atoms from water molecules through the pore of the
hexamer bundle. From left to right, data from the following models are plotted: φ = 40º,
43º, 88º, 192º, 300º, and the antiparallel model. The density is expressed in number of
atoms per Å, and plotted as a red line along the horizontal axis. For comparison, the
density profile from the φ = 40º model is also shown as a dashed blue line in the other
models (duplicated for the antiparallel model, which is symmetric with respect to the
membrane plane). For those models featuring pore-lining Gln120 side chains, the region
occupied by their nitrogen and oxygen atoms is highlighted in green.
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2.4 Conclusion and Discussion
Comparison of the properties of the FP from PIV5 with other systems:
Here we provide experimental evidence that the FP from the PIV5 F protein is
able to adopt a TM helical conformation when incorporated into lipid bilayers, and that it
associates with the C-term-TM helix. Similarly, a FRET assay

151

suggested the C-term-

TM domain of influenza HA interacts with its FP, although the orientation of the peptide
in the complex was not determined. These findings extend the structural and mechanistic
similarity between the PIV5 fusogenic F protein and SNARE proteins to include not only
their water-soluble coiled-coil domains, but also their membrane-interactive domains.
Recent biochemical and structural studies on SNARE proteins

131

suggest a zippering

motion of the water-soluble coiled-coils that continues into the TM domains promoting a
heteromeric interaction between the two TM helices to provide part of the driving force
for bilayer fusion.

The conformation and TM orientation of the FP from the PIV5 F protein is clearly
defined by IR dichroism (Figure 2.6), which showed an average helical tilt of 20° to 30°
relative to the membrane normal, and also ruled out the possibility of significant amounts
of β-structure. The situation is less clear for other FPs, which often are found to adopt
more “oblique-oriented” or “tilted helical conformation”

152

, in which the helix is

oriented at 30 to 70° relative to the bilayer normal, either spanning the bilayer or
penetrating a single leaflet, depending on the length of the synthetic peptide investigated
41

96-98, 109, 116-118

TM

99

, tilted

. For example, the N-terminal peptide of gp41 has been reported to adopt a
112-114

, and beta

103, 110-112, 115

conformation in various membrane mimetics.

Synthetic versions of the FP from influenza virus HA2 span approximately half of the
bilayer width, but as a bent helix

96

or helical hairpin

102

in micelles. However, the

hydrophobic region of the FP in the intact virus spans residues up to Arg25, while NMR
studies have been conducted with peptides spanning between 20 to 23 residues, with an
artificial oligo-Lys tail added to enhance water-solubility. The dynamics and
conformational properties of the 20- versus 23-residue peptide differ significantly

102

, as

expected for a finely tuned system with multiple low-lying energy wells that are
progressively populated during fusion. These distinct structural states, and their
sensitivity to small changes in sequence and environment, may be both functionally
relevant and reflect the energetic fine-tuning of the landscape and the dynamic nature of
fusion.

Within a family, the FPs of viral fusion proteins have highly conserved sequence
motifs, such as heptad repeats of small residues, that are similar to those important for
association of other oligomeric TM helical bundles

75, 128, 129

(Table 2.1), suggesting that

TM helix-helix association might be relevant to fusion. In this regard, it is interesting to
compare the avidity of homo- and hetero-oligomer formation for the C-term-TM and FP
of the PIV5 F protein. Isolated FPs homo-oligomerize strongly and specifically to a 6HB.
The C-term-TM peptide also engages in helix-helix interactions, which have been
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experimentally demonstrated using disulfide crosslinking of the full-length protein138.
However, the present study shows that the C-term-TM helix homo-oligomerizes more
weakly than the FP in the absence of the trimeric ectodomain, but associates tightly with
the FP (Figure 2.4). The hierarchy of association strengths mimics the assembly process
of the ectodomains, in which the weakly associated parallel C-terminal coiled-coil trimer
(contiguous with the C-term-TM helix) dissociates and zippers up along the N-terminal
coiled-coil (contiguous with the FP) to form the final antiparallel bundle85-88. The C-termTM and FP may likewise zipper as an antiparallel bundle in forming the postfusion state.

A provisional model for membrane fusion by class I proteins: lipid-centric and “pinprick” mechanisms.
In the absence of fusion proteins, the process of bilayer fusion is a physical
process with multiple high-energy intermediates

153, 154

corresponding to: 1) diffusion of

the membranes together; 2) dehydration of the bilayers as the headgroups of opposing
bilayers come into still closer proximity; 3) formation of a lipidic stalk, 4) hemifusion, 5)
pore formation and expansion. Viral fusion proteins and SNARE proteins utilize
essentially irreversible, energetically favorable conformational transitions to lower the
activation energy for membrane fusion

131, 132, 153, 154

. Thus, they are active participants

that shape the energy landscape. There are multiple classes of fusogenic proteins, and
there is significant variation in the number of fusion proteins per particle, suggesting
additional biological requirements, presence of accessory proteins, or lipid compositions
43

86

. Here we consider how the class I fusogenic proteins might orchestrate energetic

landscape-shaping mechanisms. The present observations provide molecular detail to two
limiting hypothetical models, representing extremes in a continuum of kinetic pathways
that depend on the protein and experimental variables.

In a “lipid-centric” model of viral fusion, the proteins hold the bilayers in close
proximity to promote the progression through lipidic intermediates of fusion (Figure
2.11A). The FP and C-term-TM domains are hypothesized to remain outside of the point
of membrane apposition, which is instead made up exclusively of lipids. The ability of
the FP to embed deeply into the membrane and engage in favorable C-term-TM to FP
interactions provides a mechanism for forcing the two bilayers into close proximity
within a very small area, as the coiled-coil domains of pre-associated proteins zipper
through the water-soluble regions and extend into the membrane. Favorable FP to Cterm-TM interaction provides a continuously downhill process for the protein component,
facilitating bilayer-bilayer apposition. Moreover, for systems in which many fusion
proteins are required for fusion, the association of the FP in target membranes might
bring sufficient fusion proteins near the protein-free zone.

A second model of fusion envisions that fusion proceeds via an initial contact
between the TM domains in the two bilayers.. The central point of protein contact can be
thought of as a “pin-prick” that expands into a fusion pore. This model is in contrast to
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those that propose a gap junction-like pore

107

as only the initial contact is mediated

solely by protein domains. The 6HB is hypothesized to be at the center of the contact
region between the two membranes. Subsequent pore formation involves the initial
protein contact expanding with recruitment of additional lipids with their headgroups
facing the growing fusion pore (note the incursion of phospholipids in Figure 2.11B).

To probe the hypothesized mechanism further, we built models of two bilayers in
the process of fusion, and asked how the previously defined structural intermediates of
the water-soluble and membrane domains of the protein might map onto likely lipid
intermediates, lowering the activation energy of the process. Figure 2.11 shows how a
hexamer of the PIV5 FPs might serve as a pin-prick to nucleate a pore at three critical
points: the extended prehairpin intermediate (left), membrane apposition (center), and
postfusion (right). As the conformational change progresses the TM bundles formed by
the C-term-TM and FP helices first dock, then coalesce into heteromeric bundles. The
initial zone of inter-membrane contact involves favorable protein-protein interactions
rather than energetically unfavorable dehydration of the bilayer headgroups, and the
fusion of these two helical bundles provides a low-energy pathway to direct fusion of the
bilayers, which remain associated with the TM bundles throughout the process.

The latter mechanism provides a rationale for the multiple conformational forms
and strong intra-family conservation in the FP sequences, which must associate with
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graded affinities in a homomeric as well as heteromeric fashion. It also explains how the
addition of various shaped lipids can either promote or inhibit fusion. As the protein
conformational change proceeds, the C-term-TM and FP become more tilted (relative to
the normal of the initial bilayer). The driving force for tilting includes the zippering of the
coiled-coil and favorable heteromeric TM interactions. The recent structure by Rees and
coworkers of the MscL MS channel

130

illustrates how mechanical forces from external

domains and lipid-specific effects result in changes in helical tilt and channel radius.
Changes in the membrane lateral surface pressure profile cause helices comprising the
MscL channel to slide relative to each other, increasing their tilt and opening the channel
like a diaphragm. In a similar manner, mechanical forces from conformational changes as
well as lateral surface pressure effects associated with the lipid composition would couple
to the energetics of protein-mediated bilayer fusion.

The highly conserved small glycine and alanine residues, which are found in both
MS channels and class I viral FP (Figure 2.1, Table 2.1), are ideally suited for helix
sliding because they present relatively smooth interfaces

74, 128

. The channel formed by

MscL also expands with these conformational changes, both opening the channel and
increasing the surface area available for protein-protein interaction. The hypothetical
tilting of the FP and C-term-TM domains would increase the number of residues in
contact with the hydrophobic region of the bilayer beyond the length of 20 residues
typically seen for TM helices. This longer membrane-suitable region is observed for the
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PIV5 C-term-TM and contributes to fusion 138. It is also observed in other viruses such as
influenza

132

and HIV, where shortening the length of C-term-TM helices can halt the

fusion process 155, 156.

Figure 2.11A compares the lipid-only and pin-prick mechanisms; in both cases
protein-protein interactions between membrane-embedded helices bring the two bilayers
into intimate contact. After the bilayers are brought close together, different proteins
might take different pathways to achieve fusion. The zone of adhesion can widen to
create a hemifusion intermediate, particularly for situations in which one of the two
helices does not fully span the bilayer (Figure 2.11A). Alternatively, the protein might act
as a pin-prick to nucleate the fusion pore (Figure 2.11B). The requirements for tight and
specific interactions between the membrane-embedded helices will also vary depending
on the specifics of the mechanism.

Overall, it seems likely that a continuum of mechanisms is needed, with proteinrich and lipid-rich patches in the fusion pore for many proteins. This in turn will allow for
failures leading to lipid mixing-arrested hemifusion when the fusogenic peptides are
mutated. The present work favors a protein-centric but not a protein-only fusion
mechanism. The pin-prick mechanism should face a less difficult pathway for interbilayer interaction to initiate the pore. In addition, it bridges SNARE-like and virus-like
mechanisms while explaining why different angles of insertion have been observed for
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various fusion peptides. Thus, this mechanism provides a general framework for
understanding protein-mediated membrane fusion.

Figure 2.11 Provisional model of PIV5 fusion. (A) Schematic diagrams of the limiting
extremes of lipid-centric and pin-prick fusion. (B) Shown is a model of the
conformational change of the F protein (FP) hexamer (6HB) from a pre-hairpin, extended
intermediate (left) to a point of membrane apposition (middle) and finally to the
postfusion state (right). Proposed conformations of the FP 6HB are shown in the insets
along with 90º rotations. Note the increased tilt of the FP moving from the extended
48

intermediate to the point of membrane apposition as well as the recruitment of lipid
headgroups to the nascent pore. FPs are shown in red and blue, C-term-TMs are shown in
magenta and yellow. The C-term-TM in the middle image contains two trimeric
structures 138.
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2.5 Method
Peptide Synthesis, cleavage and purification
The

wild-type

sequence

for

PIV5

fusion

peptide

(FP)

is

FAGVVIGLAALGVATAAQVTAAVALVKANE. The only glutamine, residue 120
(using the numbering of the fusion protein before cleavage), was mutated into alanine for
the mutant Q120A. One tryptophan was added to the C-terminus of both the wild-type FP
and the mutant Q120A using a flexible (Gly)3 linker in order to provide absorbance at
280 nm for concentration measurements.

The sequence for C-terminal membrane

segment TM (C-term-TM) peptide is VLSIIAIALGSLGLILIILLSVVVWK, and contains
a tryptophan for concentration measurements.

Peptide synthesis, cleavage and purification were conducted as previously
described

139

. 0.1 mmole scale synthesis was manually conducted on RINK amide resin

(Novabiochem) by N-9-fluorenylmethyloxycaronyl (Fmoc) amino acids (using a fourfold molar excess) in a microwave synthesizer (CEM Discover).

The peptide was

cleaved using a trifluoroacetic acid (TFA):water:1,2-ethanedithiol ratio of 95:2.5:2.5.
Peptide purification was run on a semi reverse phase HPLC (Vydac, C4 column, 250mm
x 10mm i.d.) at 60º C in a gradient between solvent A (water with 0.1% TFA) and
solvent B‟ (isopropanol: acetonitrile:water in a ratio of 6:3:1 with 0.1% TFA). The
identity and purity of the peptide were confirmed by MALDI-TOF mass spectrometry
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(Voyager model DE RP; PerSeptive Biosystems) and analytical reverse phase HPLC
(Vydac C4 column).

Sedimentation equilibrium of analytical ultracentrifugation (AUC)
Sedimentation equilibrium experiments and data analysis were performed as
described previously

82, 139, 141

. Wild-type and mutant Q120A FPs was mixed with

dodecylphosphocholine (DPC) in 2,2,2-trifluoroethanol (TFE). The cocktail was dried in
a glass vial, lypholized over night, and rehydrated with buffer in order to reach the DPC
concentration of 8mM. This pH-7.3 buffer contained 100 mM HEPES, 100 mM NaCl
and 37% D20 in order to match the density of the detergent.

Three groups of samples were prepared as peptide:DPC molar ratios of 1:50,
1:100 and 1:200. The experiments were conducted at 25ºC using a Beckman XL-I
analytical ultracentrifuge at 30, 35, 40, and 45 kRPM. In addition, some samples used
additional experiments at 48 kRPM. Data obtained were globally fitted to a nonlinear
least-squares curve by IGOR Pro (Wavemetrics) as previously described 157.

Two AUC experiments were carried out to identify the interaction between the FP
and the C-term-TM peptide. First, the C-term-TM peptide alone was prepared as a
peptide:DPC molar ratio of 1:100. No significant curvature has been observed in AUC
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data despite running the sample at multiple speeds (30, 35, 40, 45 and 50 kRPM). The CTerm-TM peptide and the FP were mixed in a 1:1 molar ratio at a total peptide:DPC
molar ratio of 1:50 (Figure 2.4B left side) and 1:100 (Figure 2.4B right side). The
experiments were conducted under the same conditions as those for the FP alone. The FP
used here was synthesized using the original sequence, without Trp labeled, thus the FP
itself did not have absorbance at 280nm. The significant curvature from the mixture
suggests the strong interaction between C-term-TM peptide and FP. The concentration of
the C-term-TM peptide was identified based on the absorbance at 280nm. The
concentration of the FP was identified using a micro-balance and dissolved in TFE. Thus
the determined concentration for the FP here might have 5% error from absorbing water
from atmosphere, and presumably contributed the fitting error in the left side of the
curves.

To estimate a lower limit of the strength of C-term-TM association with FP, the
avidity of C-term-TM homooligomerization with and without FP were compared. For Cterm-TM alone, the association is weak. The midpoint occurs in the range of 1:3-1:5
peptide:detergent. The midpoint is similar when fit as a dimer, trimer, or hexamer. In the
presence of FP, the midpoint of heteromeric association occurs at approximately 1:100
peptide:detergent. Because the heteromeric interaction appears to involve an equal
number of FP and C-term-TM peptides, for this calculation the molecular weight,
extinction coefficient, and partial specific volume values for the FP and C-term-TM were
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averaged and fit to a monomer-12mer equilibrium. The ratio of these self-association
values provides a conservative estimate of C-term-TM association of at least 20 times
stronger association in the presence of FP than in isolation.

Circular Dichroism (CD)
CD spectra were collected with a Jasco J-810 spectropolarimeter and a 0.1 cm
quartz cell using a 1nm step at 25ºC. Peptide at 12.5 μM was incorporated into 2.5 mM
detergent DPC using the method described above and rehydrated into aqueous buffer
containing 10 mM disodium phosphate of pH 7.4. The CD spectrum of each peptide was
obtained by subtracting the spectrum of DPC alone and averaging over three scans.

Attenuated total reflection IR spectroscopy (ATR-IR)
ATR-IR experiment and data analysis were conducted as previously described 143,
144

. 140 μL of 300 μM wild-type or Q120A mutant FP was mixed with 25.5 μL of 32.9

mM 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), in order to make a
peptide:POPC ratio 1:20. The cocktail was loaded on the surface of ATR Ge crystal
evenly and dried by air. The film was rehydrated by D2O-saturated air overnight in
closed environment of D2O bath.

All infrared spectra were measured in a Nicolet

Magna-IR 860 spectrometer using 1 cm-1 resolution. During data acquisition high-purity
N2 gas continuously purged the spectrometer and D2O hydrated high-purity N2 gas was
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continuously purged upon the sample film to eliminate the spectral effects of water in air.
The polarized mirror was adjusted to 0º and 90º in order to create incident light oriented
parallel and perpendicular to the lipid normal, respectively. Each spectrum of a peptide
was subtracted by the spectrum of the crystal alone at 0º and 90º, respectively. A total of
64 scans were averaged and Fourier-transformed to both wild-type and mutant. The
dichroic ratio of 1656 cm-1 amide I bond absorption is computed for parallel (0º) versus
perpendicular (90º) polarized incident light relative to the membrane normal. The
dichroic ratio was then applied to equations in

143

, in order to calculate the peptide

orientation relative to the membrane normal.

Sequence conservation
Because buried positions are more conserved than solvent or lipid exposed
positions, an α-helix will, in general, show a sinusoidal conservation pattern with
approximately 3.6 residue periodicity

158

. If the helix is bent as part of a coiled coil,

seven residues occur over every two turns of the helix, giving an average of 3.5 residue
periodicity. A beta sheet, however, would be expected to show approximately 2 residues
per period, as the residues alternate sides of the strand.

To determine the sequence conservation of the FP, sequences from the NCBI nonredundant database (February 9, 2009) were selected if the sequence matched the PIV5 f54

peptide sequence (FAGVVIGLAALGVATAAQVTAAVAL) to an E-value of 1 or less
159

.

The program Cd-hit

160

was used to remove sequences with higher than 90%

sequence identity. The sequence entropy of each sequence position is calculated as:
Entropy = -Σ i = 1,20 { fi ln fi }, where fi is the fraction of residue i. The entropy, x, was fit
to a sine wave according to the formula: y = a*sin[2π(x+b)/c] + d, where the periodicity is
found in variable c.

Creation of coiled coil models
All-atom protein backbones of the TM coiled-coil FP hexameric bundle (6HB)
were created using the Crick parameterization
method

161
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according to a previously published

. Three parameters were allowed to vary: alpha helical phase (φ), pitch angle

(α), and superhelical radius (R). The other coiled coil parameters were held fixed. φ was
varied from 0º to 359º in 1 deg steps; α from 5º to 20º in 1 deg steps; and R from 9.0 to
11.0 Å in 0.1 Å steps. These ranges were chosen based on the values observed in other
coiled coils and such that no backbone clashes would occur in the complex.

For each backbone 6HB model, side chains were placed using the program scap
162

and hydrogens placed by reduce

163

. Each structure was subject to a constrained

minimization in CHARMM22 147 of 50 steps to decrease, but not remove, the penalty for
a clash in a given structure and to not move significantly from the initial coiled coil
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parameters. The energy of the structure was then calculated using CHARMM22 and
IMM1 implicit solvation 148 with a non-bonding interaction cutoff of 9.0 Å. The selected
minimized models had the following (φ, α, R) parameters before simulation: (40º, 10.3 Å,
22.1º), (43º, 10.4 Å, 15.9º), (88º, 10.4 Å, 16.0º), (196º, 9.7 Å, 13.6º), and (300º, 10.7 Å,
15.6º).

The parameters of the antiparallel model were: (24º, 10.2 Å, 9.0º) with a z-offset

of 0.5 Å.

Molecular dynamics simulations
Models of the FP hexameric bundle (6HB) were embedded in a lipid bilayer
composed of 140 POPC molecules (80x80 Å in size), capped on each side by a water
layer of 18 Å thickness (6,500 water molecules in total). Periodic boundary conditions
were applied. 11 Na+ and 11 Cl- ions were distributed in the water region, corresponding
to a salt concentration of about 150 mM. The six peptides and the ions were described by
the CHARMM27 force field 164, the water molecules by the TIP3P force field 165, and the
lipid molecules by the united-atom force field recently developed by Hénin et al, which
provides nearly identical physicochemical properties to the CHARMM27 lipid

166

. The

van der Waals interactions were truncated at 12 Å, and a grid resolution of 0.75 Å was
used to treat the electrostatic interactions with the Particle-Mesh-Ewald (PME) scheme
167

.
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Each 6HB system was simulated by molecular dynamics (MD), using a time step
of 2 fs. A Langevin thermostat

168

was applied to maintain a temperature at 310 K (~37

C), and a Langevin-piston barostat 169 to keep a pressure of 1 bar along the bilayer normal.
In the two directions parallel to the membrane, instead, a constant surface tension of 20
dyn/cm2 was enforced.

The NAMD program

170

was used to perform all the MD

calculations presented here.

Because the interactions between the peptides and the surrounding lipids are of
major importance to this study, and due to the fact that the starting HB structures were
modeled within an implicit membrane, a rather long equilibration phase was performed.
For each starting structure, a restraint of 10 kcal/mol/Å was applied to the peptide heavy
atoms for the first 2 ns, and on the backbone heavy atoms only for the following 7 ns.
The time evolution of the system was monitored during the following 50 ns of MD
simulation without restraints.

The density of water oxygen atoms in Figure 2.8 was computed by counting all
atoms within a radius of 12 Å from the central axis of the bundle. We used this criterion
to account for the wide aperture of certain 6HB models (φ = 88º, 300º) and the
oscillations of the bundle with respect to the membrane normal, while not including at the
same time a detectable number of water molecules in the lipid interstitial regions: water
density profiles computed with different radii do not differ significantly between z = -15
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Å and 15 Å. The water density isosurface in Figure 2.9B shows instead the distribution
of all water molecules of the system in the HB (φ = 40º) simulation.

FTIR Dichroism calculations
Following the method of Arkin and coworkers150, we calculated the expected
dichroism ratio by summing the contributions to carbonyl groups to each polarization
given the backbone dipoles vectors in the molecular dynamics trajectory. For these
calculations 5% disorder was assumed. Because non-helical termini and the first three
helical residues are expected to exchange with D2O, only residues 108 through 126 were
used for the calculation. Including the full FP gives very similar results.

Modeling of the fusion process
To model the fusion process, both the PIV5 F protein and the membrane needed
to be modeled. A 200 Å by 200 Å POPC lipid bilayer was created using VMD
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. For

early stages of the fusion model, the bilayer was perturbed using a cosine function with
an increasing amplitude centered at the region that would become the point of membrane
apposition.

Later stages incorporated increasing fractions of the conformation of a

catenoid that makes up the final, postfusion conformation of the model. The diameter of
this pore is estimated to be 20 Å based on experimental results for influenza
hemagglutinin

105, 172

. For the catenoid, the midpoint of the membrane followed the
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mathematical formula while lipids were rotated to be perpendicular to the surface. Lipid
density was maintained between the initial flat membrane surface and the catenoid
structure.

To model the F protein, first the available prefusion and postfusion crystal
structures were combined to create a model of the prehairpin intermediate that bridges the
viral and target cell membranes. Transmembrane domains were modeled either as coiled
coils extended into the membrane or using the existing model of the prefusion TM

138

.

Loops were modeled using loopy 173, the side chains were repacked using Rosetta 174, and
the structure minimized using the CHARMM22 energy function

147

. The structure of the

postfusion state comes from the closely related hPIV3; the sequence of PIV5 was
threaded onto the structure using Rosetta and minimized using the CHARMM energy
function.

For fusion intermediates, the membrane associated domains were first modeled.
The hexameric model of the fusion protein was taken as the initial state for the prehairpin
intermediate. The helices were then tilted in 10º increments and slowly moved outward
from the center to mimic the conformational change proposed for the MscL channel

130

.

In parallel, two TM domain trimers 138 were initially at a distance due to the conformation
of the prehairpin intermediate, then brought close together and tilted relative to each other
as may occur under the tension caused by zippering of the soluble coiled coil domains.
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The soluble portions of the F protein trimers were tilted to connect to the FPs at
each step. Loops between the FP and HRA were connected using loopy

173

and Pymol

sculpting. The conformation of the exterior coiled coil, HRB, was then modified to
connect to the TM domain using an loopy in-house loop modeling program and the BBQ
backbone modeling program 175.

2.6
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Yao Zhang performed all the experiments and related analysis in this chapter,

Jason E. Donald, Giacomo Fiorin, Vincenzo Carnevale, and David R. Slochower
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3 Chapter 3: Experimental and computational evaluation of
forces directing the association of transmembrane helices

3.1

Abstract
The forces that define the interactions of transmembrane helices have been

evaluated using a model membrane-soluble peptide (MS1), whose packing is modeled on
the two-stranded coiled-coil from GCN4. The thermodynamic stability of water-soluble
coiled-coils depends on the side chain at the buried a position of the repeat, favoring
large hydrophobic residues over small side chains. Here we show that just the opposite is
true for the membrane-soluble peptide. Analytical ultracentrifugation and equilibrium
disulfide interchange show that the stability of MS1 is greatest when Gly is at each a
position of the heptad repeat (MS1-Gly), followed by Ala > Val > Ile. Moreover, MS1Gly has a strong tendency to form antiparallel dimers, MS1-Ala forms a mixture of
parallel and antiparallel dimers, while MS1-Val and MS1-Ile have a preference to form
parallel dimers. Calculations based on exhaustive conformational searching and rotamer
optimization were in excellent agreement with experiments, in terms of the overall
stability of the structures and the preference for parallel vs antiparallel packing. The
MS1-Gly helices are able to achieve more favorable and uniform packing in an
antiparallel dimer, while MS1-Val and MS1-Ile have more favorable van der Waals
interactions in a parallel dimer. Finally, the electrostatic component arising from the
partial charges of the backbones become significant in the antiparallel MS1-Gly and
MS1-Ala conformations, due to close packing of the helices. Thus, van der Waals
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interactions and electrostatic interactions contribute to the stability and orientational
preferences of the dimers.
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3.2

Introduction
While our understanding of the features stabilizing the structures of water-soluble

proteins has reached an advanced state, a parallel understanding of membrane protein
folding is only beginning to emerge.59 Previous work on water-soluble proteins suggests
that the burial of hydrophobic residues plays a crucial role for folding.176, 177 Similarly,
the replacement of large apolar sidechains with smaller residues in the interior of
membrane proteins results in introduction of cavities with a concomitant loss in
thermodynamic stability.178 From this perspective, the packing of large apolar sidechains
can stabilize the folded structure of membrane protein. By contrast, statistical,74, 75, 179-181
computational77, 182, 183 and experimental77, 182, 184 studies have demonstrated that small
side chains, such as Ser, Ala and Gly, occur frequently at the helix-helix interface of
membrane proteins, suggesting that the appropriate packing of these residues might
provide an even stronger driving force for transmembrane (TM) helix association. We
therefore compared the effects of packing large vs. small apolar sidechains, using a
simple transmembrane TM helical dimer.

Coiled-coils, such as the leucine zipper from GCN4,176, 177 have a repetitive 7residue repeat providing a conceptually simple system for studying sidechain packing. By
convention, the residues at the a and d positions of the heptad pack in the core of a coiled
coil. The stability of water-soluble coiled-coils scales with the size and hydrophobicity
of the sidechains at the a position increasing over the series Gly < Ala <Val < Ile.177, 185
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Interestingly here we show just the opposite rank for MS1, a membrane-soluble version
of a leucine zipper.
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3.3

Results and Discussions
MS1 is a membrane-soluble derivative of GCN4-P1, rendered lipophilic by

converting its exposed polar sidechains to apolar residues, while maintaining the core
residues constant.60 We synthesized a series of MS1 variants in which each of the four a
positions was varied to Gly, Ala, Val and Ile (Figure 3.1). Each of these peptides is
predominantly helical in dodecylphosphocholine (DPC) micelle as determined by circular
dichroism over the entire range of peptide/DPC ratios studied here (Figure 3.2). Their
assembly was first examined in DPC micelles by analytical ultracentrifugation (AUC)
under conditions where the density of the solution is adjusted by addition of D2O to
eliminate the mass contribution of DPC. The degree of association of membrane peptides
in micelles depends on the concentration of peptide in the micelle phase as reflected in
the peptide/detergent ratio. Over all experimentally accessible peptide/detergent ratios,
MS1–Gly was fully dimeric, MS1-Ala adopted a monomer-dimer equilibrium, and the
most hydrophobic peptides, MS1-Val and MS1-Ile, were predominantly monomeric
(Table 3.1, Figure 3.3). This ranking is precisely the opposite of that found in watersoluble structures.

To explore the association strength of the MS1 variants we employed the method
of equilibrium thiol/disulfide exchange,141 which is well-suited for examining weak
interactions. The N-terminus was modified with a flexible three-glycine linker followed
by a cysteine (Figure 3.1C). After peptides were incorporated into detergent micelles,
redox buffer was added to bring the system to the following equilibrium (scheme 1).
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Scheme 1.

2MonSH
Kdim

Kdim

[DimSH]
[MonSH]2

GSSG
DimSH
Kox

2GSH
DimSS

Kox

[DimSS][GSH]2
[DimSH][GSSG]

The two steps in scheme 1 are linked but depend differently on the peptide
concentration: the dimerization step (Kdim) is a reversible bimolecular association
reaction that depends on the reduced monomer concentration (MonSH); the subsequent
oxidation step (Kox) is also reversible, but independent of the concentration of the peptide
and dependent on the ratio of oxidized (GSSG) to reduced glutathione (GSH). Using this
function we fit curves to obtain the parameters Kdim and Kox for each MS1 variant (Table
3.2; Figure 3.4, 3.5A). Comparison of ∆Gdim for each variant suggests that the amino acid
in the a position aids the association of membrane helices in increasing order of: Gly >
Ala > Val > Ile, in good agreement with the AUC data. Clearly, the association of the
helices increases as the size of the core positions side chain decreases.
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Figure 3.1 Helical wheel (A), computational model showing side and top view (B), and
sequence of MS1 variants (C). MS1, -Gly, -Ala, -Val, and –Ile are N-terminally Cysmodified. –Gly-(Ct) is C-terminally Cys-modified. The variable a positions are shown in
green, and the Leu at d in red. All peptides had an N-terminal acetyl group.
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Figure 3.2 CD Spectra of MS1 variants (units are deg cm2 dmol-1 res-1). The spectra
show that all peptides are predominantly α-helical at a peptide/detergent ratio of 1/1000
or 1/50 (matching the concentration range for the thiol-disulfide exchange equilibria).
The magnitude of the ellipticity at 222 nm is the same within the experimental error,
which derives primarily from the concentration determination used to compute the mean
residue ellipticity. Buffer conditions and other methods are given below.
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Figure 3.3 Sedimentation equilibrium analysis of the reduced MS1 variants in DPC
micelles: (A) MS1-Gly, (B) MS1-Ala, (C), MS1-Val, (D) and MS1-Ile. The absorbance
was measured at 280nm. The top panels shows the residuals of single species fitting to
data at respectively 30, 35, 40, 45, 48 KRPM. (E) MS1-Ala is fitted with monomer-dimer
equilibrium, resulting in pKdim equal to -1.3. In this analysis the concentration of peptide
is mole ratio of peptide/detergent, and hence is unitless. (F) Monomer/dimer species
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distribution of MSI-Ala as a function of peptide/DPC ratio based on fitting in (E). Buffer
conditions and other methods are given below.

Table 3.1 Association states of MS1 variants determined by AUC

a

Observed MW

Monomer MW

Ratioa

MS1-Gly

6300±600

3214.4

2.0±0.2

MS1-Ala

5600±200

3270.5

1.7±0.1

MS1-Val

3200±300

3359.3

1.0±0.1

MS1-Ile

3100±500

3438.8

1.0±0.2

Ratio = Observed MW / monomer MW

Table 3.2 pKdim and pKox obtained from analysis of data in Figure 3.2A
pKdim

pKox

∆Gdim (Kcal/mol dimer)_

MS1

-2.6

1.5

-3.6

-Gly

-3.0

2.6

-4.1

-Ala

-1.6

1.2

-2.2

-Val

0.9

-0.8

1.2

-Ile

1.9

-2.0

2.6

The error is estimated to be approximately 10% based on the error in experimental
concentrations of the reduced and oxidized peptides

70

Figure 3.4 Simulation of disulfide exchange equilibrium related to various dimerization
affinities (Kdim) and redox ratios (Kox). The figure shows theoretical fractions of
crosslinked dimer as a function of peptide/DPC ratio at (A) varying pKdim (pKox=0), and
at (B) varying pKox (pKdim=0). Note that the shapes of the curves vary depending on both
parameters. Thus, the figures demonstrates that thiol disulfide equilibrium method is
sensitive to both the free energy of association as well as and redox potential for a given
peptide.
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Figure 3.5 (A) Analysis of the fraction of crosslinked dimer as a function of peptide/DPC
ratios for each MS1/variant. The theoretical curve describes the least-squares fit to
scheme 1 (Table 3.2). The standard errors in the experimental points are similar for each
peptide and are indicated for MS1-Ile (Others are not so shown for clarity). (B) HPLC
chromatogram after redox equilibration of the C-terminal and N-terminal Cys-modified
MS1-Gly mixture indicates that MS1-Gly prefers an anti-parallel orientation. The other
peaks are glutathione adducts.
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Interestingly, as the size of the side chain at the a position decreases, the ease of
disulfide formation (reflected in Kox) becomes less favorable. This was surprising, given
that the peptides have a Gly3 linker between the helical ends and the Cys. As long as the
helices pack in a parallel manner, the flexibility of the linker should easily accommodate
any subtle differences in helix-packing (two Cys-Gly3 linkers could extend up to about
20 Å, while interhelical distances in dimers vary by only a couple Å). Thus, we
considered the possibility that MS1-Gly prefers to assume an antiparallel orientation. In
this case, association of MonSH would remain favorable, but the oxidation step would
require unfavorable intramolecular rearrangement of the antiparallel dimer, Dim (anti)SH, to
the parallel Dim(parallel)SH to allow disulfide formation, because of the need to shift the
equilibrium from one favoring antiparallel to parallel dimers upon disulfide formation
(Scheme 2).

Scheme 2.

GSSG
2MonSH

[Dim(anti)SH

Dim(parallel)SH]

2GSH
DimSS

To test this hypothesis, we synthesized a C-terminally Cys-modified peptide
(Figure 3.1C, -Gly-(Ct)), which was mixed in equal amounts with N-terminally Cyslabeled MS1-Gly under reversible redox conditions. If MS1-Gly has the same preference
to form parallel dimers as antiparallel dimers, then a ratio of 1:1:2 (N-terminal
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homodimer : C-terminal homodimer : heterodimer) is expected.

However, the

experimental ratio is 1:1:14, indicating that MS1-Gly strongly prefers to form antiparallel dimers (Figure 3.5B).

To probe further the orientation of MS1-Gly and the other variants, the peptides
with N-terminal Cys residues were individually air-oxidized to force an N-terminal
crosslink (Figure 3.6, 3.7). Under these conditions peptides with a strong tendency to
form antiparallel dimers might be expected to oligomerize as shown in Figure 3.3C. To
avoid the precipitation of polymers during centrifugation we performed the experiment
on samples that were approximately (75±5)% oxidized. The ratio between the computed
molecular weight from a single-species fit and the computed monomeric molecular
weight roughly reflects the degree of oligomerization (Table 3.3). The computed ratio for
MS1-Gly is 6.9, supporting the expectation that MS1-Gly prefers an anti-parallel
orientation. MS1-Ala has a ratio of about 3, in agreement with the conclusion that this
peptide prefers to form weak, antiparallel dimers. The ratio for MS1-Val and MS1-Ile is
less than two, again consistent with the suggestion that they form even weaker parallel
dimers. Thus, as the side chains in the core positions become smaller, the helices prefer to
form antiparallel orientation.
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Figure 3.6 Analytical ultracentrifugation of approximately 80% disulfide-bonded MS1Gly (A) and MS1-Ile (B). The greater degree of curvature in panel A vs. B is indicative
of greater oligomerization. (C) Oligomerization of MS1-Gly and MS1-Ala via formation
of antiparallel dimers.
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Figure 3.7 Sedimentation equilibrium analysis of the MS1 variants in DPC micelles: (a)
MS1-Ala and (b) MS1-Val. Absorbance is measured at 280nm. Top panels shows
residuals of single species fitting to data at respectively 30, 35, 40, 45, 47 KRPM.
Peptides were first air-oxidized in buffer. The percentage of air oxidized dimer was
determined by analytical HPLC to be (75±5)%. Buffer conditions and other methods are
given below.
Table 3.3 Degree of association of air-oxidized MS1 variants in DPC micelles
determined by analytical ultracentrifugation
Observed MW

Monomer MW

Ratioa

MS1-Gly

22200±800

3214.4

6.9±0.1

MS1-Ala

9200±1200

3270.5

2.8±0.4

MS1-Val

5000±1700

3359.3

1.5±0.5

MS1-Ile

4300±1300

3438.9

1.3±0.4

a

Ratio defined as in Table 3.1 (Main text). The errors are large for low observed MW,
due to the small curvature in the radial distribution curves, adding uncertainty in the fitted
baseline parameter.
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To investigate the energetic and structural mechanisms behind these observations
we built parallel and antiparallel computational models for the MS1 variants. While long
simulations in bilayers would be essential to fully evaluate the relative energetic
contributions from helix-helix, helix-lipid and lipid-lipid components, successful
models186 and designs82 of transmembrane proteins have been achieved by probing helixhelix packing interactions alone, using a much simpler gas phase potential energy
function. For each sequence, the conformational space available to parallel and
antiparallel two-stranded coiled coils (Figure 3.8A) was globally searched using a
molecular mechanics force field to compute the difference in energy between the
homodimer versus the isolated monomers as described in the supplement. The resulting
energy landscapes (Figure 3.8B) have global minima corresponding to structures in
which the variable a position projects towards the core of the structure as in Figure 3.1B.
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Figure 3.8 (A) Sampling Crick parameters for parallel (r, θ) and anti-parallel (r, θ, ztranslation) dimers. (B) Energy landscape showing the difference in computed LeonardJones energy ELJ (for the dimer versus two monomers) of MS1-Gly in a parallel
orientation. The minimum in the surface has a helical phase (θ) of 154°, allowing
packing of the Gly residues at the helix/helix interface as in Figure 3.1B.
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The calculations are in remarkable agreement with experiment, given the stark
simplicity of the calculations. The global minimum energy conformations (GMEC) for
MS1-Gly and MS1-Ala correspond to antiparallel structures, which also allow the closest
approach of the helices (Table 3.4). By contrast, the GMEC conformations for MS1-Val
and MS1-Ile, correspond to parallel structures. To gain insight into the interactions
responsible for these structures, some of the energetic components were investigated,
specifically the change in Leonard-Jones energy (ΔELJ, approximating the van der Waals
component) and the electrostatic term associated with interactions between the partial
charges of the main chain atoms at the interface (ΔEbb). The values of ΔELJ for the
GMEC structures correlate with the experimental ranking (∆Gdim), both in terms of
overall energetics of association as well as the preference for parallel versus antiparallel
structures (Table 3.5). Moreover, although the magnitude of ΔEbb depends on the
electrostatic treatment employed in these calculations, there is a clear trend towards
greater stabilization of the antiparallel structure as the residues at the a position (and
hence the inter-helical separation) become smaller.
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Table 3.4 Energetic contributions for minima in energy landscape a
Peptide

Parallel

Anti-Parallel

Δ(orientation) b

MS1-

Δ ELJ

Δ Ebb

Δ ELJ

Δ Ebb

Δ Δ ELJ

Δ Δ Ebb

Gly

-23.5

2.8

-38.0

-1.4

-14.6

-4.2

Ala

-31.8

1.8

-36.1

-0.9

-4.3

-2.7

Val

-35.2

0.8

-26.2

-1.0

9.1

-1.8

Ile

-32.3

0.4

-28.8

-0.1

3.5

-0.5

a

Units are kcal/mol based on the CHARMM Force Field. Values in bold give the values
of Δ ELJ and Δ Ebb associated with the GMECs. b Δ(orientation) represents the energetic
difference between the global minimum for the anti-parallel vs. parallel orientations.

Table 3.5. Crick parameters at the potential energy minimum
Peptide

Parallel

Anti-Parallel

MS1-

R(Å)

θ(º)

R(Å)

θ(º)

Ztrans(Å)

Gly

4.3

154

3.6

130

-2.1

Ala

4.4

152

4.3

135

-1.4

Val

4.6

154

4.5

145

-1.8

Ile

4.9

146

4.8

150

-1.2

See Figure 3.8A (main text) for description of parameters
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3.4

Conclusion and Discussion
These studies together with other studies of MS1 variants77 show that small

residues at TM helix-helix interfaces allow helices to come into close contact,
concomitantly increasing their van der Waals interactions.80,

180

Thus, they are in

agreement with previous studies highlighting the importance of van der Waals
interaction,178 while also demonstrating the important role that small residues can play in
allowing particularly efficient packing to occur. Finally, we show that close interhelical
distances associated with packing of small sidechains can additionally facilitate
interhelical electrostatic interactions between the partial charges of backbone atoms.
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3.5 Methods
Peptide synthesis and purification
Peptides were synthesized as C-terminal carboxamides at a 0.1 mmole scale on
RINK amide resin (Novabiochem) by N-9-fluorenylmethyloxycaronyl (Fmoc) amino
acids (four-fold molar excess) on a Symphony peptide synthesizer. Standard coupling
conditions are shown in ref.141

Side chain deprotection and simultaneous cleavage from the resin was performed
using a mixture of trifluoroacetic acid (TFA)/water/triisopropylsilane/1, 2- ethanedithiol
(92.5/2.5/2.5/2.5) and precipitated with cold diethyl ether. The peptides were purified by
reverse phase HPLC using a preparative (Vydac, C4 column, 250mm x 9.4mm i.d.) in a
gradient between solvent A (water with 0.1% TFA) and solvent B (isopropanol
/acetonitrile 2:1 with 0.1% TFA). The purity of the peptides was confirmed by analytical
reverse phase HPLC (Vydac C4 column) and MALDI-TOF mass spectrometry (Voyager
model DE RP; PerSeptive Biosystems).

Preparation of peptide detergent micelles
MS1/variants and detergent dodecylphosphocholine (DPC) were dissolved in
2,2,2-trifluoroethanol (TFE) and mixed in a glass vial. The TFE was removed under a
stream of nitrogen and subsequently in vacuum. The samples were re-hydrated with
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100mM Tris–HCl (pH 8.6), 100 mM KCl and 1 mM ethylenediaminetetraacetic acid
(EDTA) unless noted otherwise.

Circular dichroism
CD spectra were acquired with a Jasco J-810 spectropolarimeter and a 0.1 cm
quartz cell at 25℃. 50μM MS1/variants were incorporated in DPC at detergent/peptide
molar ratios of 50 and 1000. CD measurements were carried out in aqueous buffer
containing 2.5 mM Tris–HCl (pH 8.6), 2.5 mM KCl and 25 μM EDTA. The CD spectra
were averaged over three scans using a 1 nm step. Baseline obtained by DPC in buffer
was subtracted from all peptide spectra.

Thiol-disulfide exchange equilibria with glutathione redox buffer
Thiol-disulfide exchange was conducted as described in reference.141 25 μM
MS1/variants were incorporated into DPC at different DPC/peptide ratios from 50 to
1000. The samples were incubated in a reversible redox condition of a glutathione buffer
containing 0.45 mM oxidized (GSSG) and 1.05 mM reduced (GSH) glutathione for 4
hours to reach equilibrium, followed by quenching with HCl at final concentration of
0.12 M. The mixtures were separated by analytical RP-HPLC and each peak was
identified by MALDI. The area of the peak was converted into mass using standard
curves.
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The data in Figure 3.2A are presented as a plot of cross-linked dimer fraction as a
function of peptide/DPC ratio, fitted by IGOR Pro (Wavemetrics) using functions derived
from equilibrium scheme 1 (see main text), resulting in minus log of the association
constant (pKdim and pKox) for all MS1/variants.

The experimental observables are the concentrations of the reduced and oxidized
species. The HPLC assay does not distinguish between MonSH and DimSS so the total
concentration of reduced species, [PepSH], is given by the sum of [MonSH] and 2[DimSH].
Glutathione adducts are also observed, but are generally much lower in concentration,
and can be neglected because the equilibria of interest required to compute Kdim and Kox
involves only the concentration of the reduced species (MonSH plus DimSH) as well as
DimSS at equilibrium.
PT = [PepSH] + 2[DimSS]

eqn: S1a

PT = [MonSH] + 2[DimSH] + 2[DimSS]

eqn: S1b

PT = [MonSH] + [MonSH]2 Kdim + [MonSH]2 Kdim.Kox.[GlutSS]/[GlutSH]2

eqn: S1c

Equation S1c was solved numerically for [MonSH] as a function of [PT], Kdim, Kox,
and [GlutSS]/[GlutSH]2 using the root-finding algorithm in IGOR Pro.

[PT] and

[GlutSS]/[GlutSH]2 are experimentally determined quantities, leaving only Kdim and Kox as
dependent variables. The data are then expressed as a plot of fraction of the peptide in the
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disulfide form (frac = 2[DimSS]/PT), and the values of the dependent variables obtained
by non-linear least squares fitting to the equation:
frac = {[MonSH]2 Kdim.Kox.[GlutSS]/[GlutSH]2}/PT + C
in which C is a constant, which was found to be close to zero for all peptides.

Disulfide formation between MS1-Gly and MS1-Gly-(Ct)
Also, in order to measure the orientation of Gly-variant dimer, 12.5μM MS1-Gly
and 12.5μM MS1-Gly-(Ct) (see Figure 3.1 in main text) were incorporated into DPC in a
ratio of 1:100. Disulfide cross-linking experiments were applied for 24 hours with
GSSG/GSH ratio of 1:4 and total concentration of 1.5 mM, followed by analytical HPLC.

Analytical ultracentrifugation
Sedimentation equilibrium experiment and data analysis were described as in
refs.82, 141 The experiments were conducted at 25 ℃ using a Beckman XL-I analytical
untracentrifuge at respectively 30, 35, 40, 45, 48 KRPM. 200 μM of each MS1 variant
was incorporated into 20 mM DPC, in a buffer containing 100mM Tris–HCl (pH 8.6),
100 mM KCl, 1 mM EDTA. Two groups of sample preparation were employed for
different purposes.
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In order to measure the oligomerization of reduced MS1 variants, 1mM Tris(2carboxyethyl)phosphine hydrochloride (TCEP) was added to buffer to keep the peptides
reduced and buffer containing 48% D2O is used to density match the detergent.
Additional multiple conditions of MS1-Gly were run at 333 μM peptide in 20 mM DPC
and 100 μM peptide in 20 mM DPC in order to make sure MS1-Gly adopts a fully dimer
conformation.

In order to measure the orientation of MS1 variants, samples were air-oxidized
overnight before sedimentation. Buffer containing 48% D2O is used to density match the
detergent. The oxidation percentage is quantitatively measured (70±5)% by analytical
HPLC after sedimentation.

Data obtained were globally fitted by nonlinear least-squares curve by IGOR Pro
(Wavemetrics) as previously described.157 Peptide partial specific volumes and the
molecular mass calculated for 48% D2O exchange were calculated using previously
described methods.187 The solvent density (1.0621 g/ml) and aqueous solution molar
extinction coefficients at 280 nm were calculated using program Sednterp. These
coefficients were multiplied by the molar detergent concentration to provide molar ratio
concentration units. All these values were kept constant during global fitting.
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Computational modeling.
The original MS1 peptide was designed using GCN4‟s backbone as a template,
which is a parallel coiled coil.60 In this work, we model the MS1 variants using a coiled
coil description of the backbone. To generate the coiled coil backbones, we used Crick‟s
equations.188 For the parallel coils, the super-helical radius and the α-helical phase were
varied to generate the model backbones. For anti-parallel coils, the super-helical radius,
the α-helical phase and the z-Translation were varied to generate the model backbones.
For coiled coils of this size, some of the degrees of freedom can be held at constant
values.161 The pitch was set to 190 Å. The rise per residue was set to 1.51 Å. The αhelical radius was set to 2.25 Å. The α-helical frequency was set to 102° (360° / 3.5
residues per turn). For computational efficiency, we modeled the MS1 sequence starting
at the residue prior to the first variable a position and including a total of 16 residues
(Figure 3.1). This is the most hydrophobic region, which should correspond to the
transmembrane portion of MS1.

Degree of Freedom
super helix radius (r)
α-helix phase (θ)
Z-translation (z)

Sampled Ranges
Parallel
Antiparallel
2.5 – 8 Å; steps of 0.1 Å
2.5 – 7.5 Å; steps of 0.1 Å
-180° – 180°; steps of 5°
-180° – 180°; steps of 5°
N/A
-3 – 3 Å; steps of 0.1 Å

To complete the models of each MS1 variant, the side-chains needed to be built
on the backbone. Each side chain, except for alanine and glycine, was modeled using 30
conformations from an energy-ranked rotamer library.189 The energy of each side-chain
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conformation with the backbone and each pair of side-chain conformations was
computed using an implementation of the CHARMM force field,190 including IMM1
membrane solvation.148 To select the proper rotamer at each position, the CHARMM
energy table was processed by an Integer Linear Programming (ILP) optimization
algorithm.191 Our C++ implementation of the algorithm uses the Gnu Linear
Programming Toolkit (GLPK)192 to solve for the global minimum energy configuration
(GMEC) of side-chains. Lastly, each model was minimized using CHARMM. The
minimization was run for 1000 steps, using the Adopted Basis Newton-Raphson
algorithm and restrained by placing harmonic forces on the backbone Cα atoms.

In order to evaluate the association energy, the energy of an isolated, ideal and
independently repacked helix was used as a reference, unbound state. The single helix for
each MS1-variant sequence was modeled using the exact same protocol as stated above.

To understand further the role of electrostatics in membrane proteins, we computed the
contribution of the interfacial residues backbone atoms (the residues that are varied in
this study) in both the winning parallel and anti-parallel models.

Because we are

interested only in the rank-ordering of the electrostatic contributions, the dielectric was
set to 1. All MS1-variant sequences preferred their anti-parallel model for electrostatics
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(based on the minimum-energy conformations of the parallel and antiparallel
conformations). However with larger residues at the interface the difference had a
marginal preference (Figure 3.9).

Figure 3.9 Electrostatics contribute to the orientation preference of MS1 variant models.
The difference between electrostatic energy in the parallel and anti-parallel models
correlates with inter-helical distance (average of parallel and anti-parallel distances). The
glycine model shows the largest electrostatic energy difference between parallel and antiparallel orientations.
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3.6

Contributions
Yao Zhang performed all the experiments and related analysis in this chapter,

Daniel W. Kulp performed the computational modeling.
This chapter has been published in Journal of the American Chemical Society,
2009:131(32):11341-3.
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4 Chapter 4: pH-switchable peptide model for membrane
insertion and pore formation

4.1

Abstract
As therapeutic potentials for macromolecules, like peptides and proteins, are

increasingly characterized, there is a need to develop the means to deliver them in to the
cytosolic environment (where these agents carry out the expected functions) across the
hydrophobic barrier of membrane. Efforts to develop a variety of intracellular drug
delivery systems as viral vector, lipoplexes, nanoparticles and amphiphilic peptides have
been made, but various challenges as delivery efficiency, toxicity and controllability
remain to be overcome. Here we have designed and characterized a series of pHswitchable pore formation (PSPF) peptides as a potential delivery agent. Successful low
pH-triggered, PSPF-mediated release specific for ATP and miRNA from red blood cells
was characterized. Furthermore, various biophysical studies (Trp fluorescence, CD, SEC,
AUC and ATR-FTIR) show that the decreased pH destabilizes the PSPF stability in
aqueous systems while promoting their membrane insertion. Together, these results
suggest a model that reduced pH drives PSPF to insert into membrane, leading to targetspecific escape through pore formation.
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4.2

Introduction
The ability to introduce targeted substances into a cell‟s interior would greatly

enhance our ability to interface with cellular processes.160, 193 Though for a small class of
molecules cellular uptake can be spontaneous, the general task, known as the delivery
problem, is largely unsolved.193,

194

This is because biological membranes serve as

effective barriers that prevent most substances from freely flowing into and out of cells
and between organelles. To allow flux of desired target, organisms depend on membraneinserted protein channels and transporters. Thus a potential solution to the delivery
problem is via engineering of custom channels or transporters.

In nature, a common feature of these carrier proteins is their controllability. A
channel or transporter responsible for the flux of an important molecule can generally be
activated or inactivated by the cell as needed.195 For example, channel-forming toxin
peptides, found in each of the three domains of life, generally become active after a
proteolytic cleavage event.196 This is also a desirable feature in engineered carrier
proteins as controlled delivery could lead to targeted delivery in pharmaceutical
applications.

Here we aim to design peptides that bind to biological membranes and form pores
only at low pH, but are minimally interactive at high pH. The pores can serve as channels
for transport of appropriately-sized target, while the pH switch provides a convenient
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manner in which to control the activity. Further, because of the lower pH environment in
the endosome, the uptake of such peptides by endocytosis could allow endosomal escape
of material present in the extracellular environment into the cell.

To realize this pH-switchable behavior, we considered three thermodynamic
states in our design process (Figure 4.1). At high pH, the peptide should be “stored” in a
water-soluble form that does not interact with the membrane. A good way to encode this
is to assure the formation of a stable water-soluble helical bundle at high pH. Lowering of
pH should destabilize this state, allowing peptide monomers to interact with the
membrane. Here we consider either a surface-adsorbed form, in which helical monomers
are engaged with the membrane surface, or a fully inserted state capable of forming a
channel. Because insertion and channel formation are thermodynamically linked, the
relative stability of the inserted versus surface-adsorbed states will have a concentration
dependence, with higher peptide concentrations favoring insertion and channel formation.

To minimize membrane association at high pH, the water-soluble bundle should
be very stable and its exterior should interact more favorably with water than the
membrane at these conditions. The most hydrophobic and potentially membraneinteracting region of the peptide is buried in the core in this state. At low pH, both of
these factors ideally need to be reversed - the stability of the water-soluble bundle should
decrease, producing a population of dissociated monomers poised to interact with the
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membrane, while the hydrophobicity of the peptide (and thus its preference to interact
with the membrane) should increase.

Figure 4.1 The desired free energy diagram of the designed peptide as a function of pH.
Lowering pH should destabilize water-soluble bundle state and stabilize first membraneassociated monomeric state and then, in a concentration-dependent manner, the
membrane-inserted channel state.

We achieve this pH modulation of stability and hydrophobicity by including
amino acids in the peptide sequence whose charge state and hydrophobicity are pH94

dependent, such as Asp, Glu and His, and considering the stability of the water-soluble
coiled coil-like bundle. In addition, we must also consider the specific inter-residue
interactions of the membrane-inserted pore in selecting the design sequence, as we are
interested in stabilizing a specific pore-forming state at low pH, rather than simply
ensuring membrane insertion. For example, peptides that simply insert into membranes or
those that insert and form indiscriminately large pores or even cause lysis are abundant in
nature,197 but would constitute unsuccessful endpoints of our design efforts either because
of lack of pore formation or potential toxicity. Thus, the overall design procedure
combined the use of pH-switchable residues with the consideration of inter-residue
contacts and stabilities of both the water-soluble as well as membrane-inserted pore states.

Here, we present the design and characterization of a series of pH-switchable pore
formation (PSPF) peptides. Several of the designed peptides associate with the membrane
in a pH dependent manner. The most promising peptides also show features of pH
dependent pore formation.
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4.3 Results
Rational selection of amino-acid choices
The design goal was to create a water-soluble peptide that associates into a stable
coiled-coil bundle at high-to-neutral pH, while preferring a membrane-inserted channel
state at low pH. This means that upon pH decrease, the nonpolar residues facing inward
in the soluble bundle, should invert and face the lipid phase in the membrane-inserted
channel (Figure 4.2). Since canonical coiled coils have only seven environmentally
distinct positions, referred to as the heptad and designated with letters a though g (Figure
4.2A), we focused on choosing the appropriate amino-acids for each of these seven sites.
Furthermore, each site in our design must play two roles - stabilizing the water-soluble,
“hydrophobic-inside” state at high pH and the membrane channel, “hydrophobic-outside”
state at low pH. To impart stability on the water-soluble bundle, we chose to adhere to the
canonical Leu-zipper coiled-coil motif, meaning that coiled-coil positions a and d were
set to Leu. These same residues face the lipid phase in the membrane channel state, and
Leu residues are ideal for this task as well (Figure 4.2B). The solvent-exposed b, c, and f
positions in the water-soluble bundle should be polar to impart solubility and fold
specificity, and these can also be used to modulate bundle stability through their innate
helix propensities. In the membrane-channel state, these positions are also water-facing,
as they point into the center of the channel, so their polar nature is appropriate here as
well. However, unlike in the water-soluble state, b and c positions are also located at the
inter-helical interface of the channel. Thus, the importance of these positions goes beyond
their physico-chemical character and includes potential interactions stabilizing specific
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interfacial conformations of channel helices. The inter-helical geometry in the channel
state is important as it ultimately defines the shape and even size of the entire channel.

Figure 4.2 The design concept illustrated using one of the designed sequences (PSPFDKG). Hydrophobic residues are either lining the bundle the core in the water-soluble
state (A), or are facing the lipid membrane in the membrane channel state (B). Dotted
circles illustrate potential hydrogen bonding in the channel state. Heptad positions in both
panels are labeled according to the water-soluble state. The amino acid choices at each
position are shown in Table 4.1.

At the f position, we chose to consider Lys or Gln - amino acids with favorable
helix propensities198 that are common at this position in coiled coils. At position b we
considered Ser because of its polar nature and relatively high helix propensity, as well as
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due to its high preponderance in closely-packing helix-helix interfaces in TM proteins.75
The c position was chosen as the pH-sensing switch. We considered amino acids Glu and
Asp at this position as their protonation state is dependent on pH, causing them to be
more protonated, less charged and thus more hydrophobic at lower pH. Although the pKa
of the carboxylic side-chains groups of Glu and Asp in water are around 4.0, somewhat
lower than the typical endosomal pH or ~5.5, significant shifting in protonated
populations would still be expected relative to neutral pH, and the collective effect of
having multiple closely-spaced acidic groups on one face of a helix will likely increase
the effective pKa of the side-chains. An additional significance of Glu and Asp residues
is their potential ability to participate in inter-helical hydrogen bonding (see Figure 4.2B),
thus further dialing in a specific, closely packed inter-helical geometry in the membranechannel state (see also structural modeling below). As a way of testing the importance of
the pH switch residue, we also considered the amino acid His at the c position. The sidechain of His titrates at pH ~6.1, but it is more charged at acidic pH than at neutral pH.
Because of this reversed pH sensitivity compared to Asp and Glu, His provides a
convenient point of reference.

Positions e and g are located along the helix-helix interface in both the watersoluble and the membrane-channel states. Because the primary driver of the watersoluble bundle stability is the canonical leucine-zipper motif, we opted to choose small
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hydrophobic residues at e and g with the primary purpose of stabilizing a closely-packed
TM helical interface75.

Table 4.1 Amino-acid choices considered in design

Position
in water

Function in water,
high pH

Position
in membrane

Function in membrane,
low pH

Amino acid
Choice

a

Helical bundle
hydrophobic core

b

Membrane-facing.

Leu

b

Solvent-exposed,
imparts solubility.

d

Small residue for helical
interface, potential interhelical hydrogen bonding.

Ser

c

Solvent-exposed,
imparts solubility.

e

Trigger residue, changes
protonation state/
hydrophobicity at low pH.
Potential inter-helical
hydrogen bonding.

Asp, Glu,
His

d

Helical bundle
hydrophobic core.

f

Membrane-facing.

Leu

e

Modulation of
helical propensity.

g

Small residue for helical
interface.

Ala

f

Solvent-exposed,
imparts solubility.

a

Solvent-exposed in channel
state (inner channel lining).
Imparts folds specificity by
encoding helical
orientation preference.

Lys, Gln

g

Modulation of
helical propensity.

b

Small residue for helical
interface.

Ala, Gly
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Based on the criteria list above, a group of sequences has been generated for the
pH-switchable pore formation (PSPF) peptide (Table 4.2).

Table 4.2 The sequence of PSPF peptides

Peptide
Heptad membrane
PSPF-DQA
PSPF-DQG
PSPF-DKA
PSPF-DKG
PSPF-EQA
PSPF-EQG
PSPF-EKA
PSPF-EKG
PSPF-HQA
PSPF-HQG
PSPF-HKA
PSPF-HKG
Heptad Water

cdefgab
WSDLAQA
WSDLAQG
WSDLAKA
WSDLAKG
WSELAQA
WSELAQG
WSELAKA
WSELAKG
WSHLAQA
WSHLAQG
WSHLAKA
WSHLAKG
abcdefg

Sequence
cdefgab cdefgab
LSDLAQA LSDLAQA
LSDLAQG LSDLAQG
LSDLAKA LSDLAKA
LSDLAKG LSDLAKG
LSELAQA LSELAQA
LSELAQG LSELAQG
LSELAKA LSELAKA
LSELAKG LSELAKG
LSHLAQA LSHLAQA
LSHLAQG LSHLAQG
LSHLAKA LSHLAKA
LSHLAKG LSHLAKG
abcdefg abcdefg

cdefgab
LSDLAQA
LSDLAQG
LSDLAKA
LSDLAKG
LSELAQA
LSELAQG
LSELAKA
LSELAKG
LSHLAQA
LSHLAQG
LSHLAKA
LSHLAKG
abcdefg

In the column of peptide names, the heptad position for the membrane-soluble form is
labeled after the one-letter amino acid code at top, and the heptad position for the watersoluble form is label after the one-letter amino acid code at bottom.
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Cellular release assays
Red blood cell (RBC) lysis assays have been used to screen the functional
efficacy of the peptides upon delivery (Table 4.3). The release of ATP, miRNA and
hemoglobin has been studied at both pH 7.5 and 5.4.

The peptide is designed to

selectively deliver the nucleotides or ribonucleic acid, with sizes similar to ATP and
miRNA, across the membrane only at pH5.5. The desirable peptide should also negate
membrane disruption, as assessed by leakage of proteins such as hemoglobin at both pHs.
Therefore the peptides were first screened for hemolytic activity at both pH 7.5 and pH
5.4. None of the twelve peptides had hemolytic activity at either pHs. When screening for
ATP and miRNA release at 5μM, PSPF-DQA, PSPF-DKG, and PSPF-EKG showed
relatively high release percentage for ATP (more than 20%) and miRNA (more than
10%) at pH 5.4, and also low release percentage at pH7.5 for both ATP and miRNA (less
than 10%). Among the top three peptides screened out of RBC assays, PSPF-EKG has
been further characterized to reveal the mechanism of action.
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Table 4.3 RBC Lysis assay of PSPF peptides

Peptide
PSPF-DQA
PSPF-DQG
PSPF-DKA
PSPF-DKG
PSPF-EQA
PSPF-EQG
PSPF-EKA
PSPF-EKG
PSPF-HQA
PSPF-HQG
PSPF-HKA
PSPF-HKG

RBC Lysis Assay (% calculated compared to triton-x-100)
Hemoglobin Release
%ATP at 5μM
%miRNA at 5μM
pH7.5
pH5.4
pH7.5
pH5.4
pH7.5
pH5.4
none
none
3.81
17.91
0.81
18.61
none
none
3.21
8.61
0.06
0.16
none
none
4.64
5.79
4.13
0.79
none
none
7.54
24.1
5.54
7.47
none
none
3.69
3.61
0.46
0.02
none
none
3.36
9.52
0.15
2.64
none
none
2.02
3.66
0.51
0.21
none
none
3.38
27.3
0.14
12.54
none
none
6.17
11.72
0.02
1.43
none
none
5.69
10.55
0.2
0.64
none
none
0.93
5.7
0.43
0.02
none
none
32.1
39.22
72.28
0.44
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Peptide engagement with the lipid bilayer by tryptophan fluorescence
To detect the engagement of peptides with lipid vesicles, tryptophan (Trp)
fluorescence was measured for PSPF-DQA, DKG and EKG. The extent of environmental
change around the N-terminal Trp was determined by the observed shift and changes in
intensity of the fluorescence signal. Blue shifts (Table 4.3), correspond to a more
hydrophobic environment, such as that which would occur to the Trp upon membrane
interaction or insertion. The majority of the PSPF- peptides studied showed minimal blue
shifting at pH 7.4 and larger shifts at pH 5.5 (Table 4.4). PSPF-DQA shows small
detectable shift at pH 5.5 (-1 nm), whereas PSPF-DKG and EKG show blue shifts of
approximately 3 nm (350 to 347 nm) each at pH 5.5. PSPF-HKG also showed a
significant shift from 351 to 341 nm at pH 5.5.

Despite different experimental conditions, Trp fluorescence shifts among all the
peptides correlate strongly with ATP release at pH 5.5, with R2 of 0.74 if linear
regression is applied (Figure 4.3). At pH 5.5, a larger shift in Trp fluorescence (likely due
to insertion into the membrane of Trp) corresponds to greater release of ATP (likely from
membrane insertion and pore formation). This suggests that the peptides are acting in a
similar manner in both experimental assays and consistent with pH-sensitive insertion
and pore formation.
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Table 4.4 Trp fluorescence of PSPF- series peptides with various amounts of lipid
vesicles.

Peptide
PSPFDQA
DQG
DKA
DKG
EQA
EQG
EKA
EKG
HQA
HQG
HKA
HKG

pH7.4
λmax (nm)
0 μM Lipid 200 μM Lipid
352
351
354
353
354
353
355
351
352
352
355
354
N/A
N/A
354
352
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Δ λmax % Intensity
(nm)# Increase*
-1
32
-1
18
-1
18
-4
36
0
6
-1
15
N/A
N/A
-2
28
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

pH5.5
λmax (nm)
Δ λmax
0 μM Lipid 200 μM Lipid (nm)
348
347
-1
350
358
-2
349
358
-1
350
347
-3
349
348
-1
349
346
-3
N/A
N/A
N/A
350
347
-3
N/A
N/A
N/A
N/A
N/A
N/A
349
347
-2
351
341
-10

% Intensity
Increase
38
33
38
38
21
42
N/A
52
N/A
N/A
34
72

# Δ λmax = λmax at 200 μM Lipid - λmax at 0 μM Lipid
*% Intensity Increase = (Intensity at 200 μM Lipid - Intensity at 0 μM Lipid)/ Intensity at
0 μM Lipid

Figure 4.3 Correlation between ATP-release by PSPF peptides and the degree of lipid
engagement as assessed by the fractional change of Trp-fluorescence signal upon
addition of 200 uM lipid vesicles.
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The association properties of PSPF peptides in an aqueous system
Size exclusion chromatography
The association state of the designed peptide PSPF-EKG was initially investigated
by size exclusion chromatography (SEC)46 using a Superdex 75 column (GE Healthcare)
eluted at pH 7.4 (150 mM NaCl, 50 mM Tris) and pH 5.5 (150 mM NaCl, 50 mM MES)
respectively. In addition, PSPF- DKG was also investigated to determine the effect of
substituting Asp for Glu on the stability of the water-soluble bundle at each pH. To
determine the approximate oligomerization states, four standards were used, shown by
blue eluting peaks in Figure 4.4: blue dextran (2,000,000 g/mol), carbonic anhydrase
(29,000 g/mol), cytochrome C (12,400 g/mol) and aprotinin (6,500g/mol).

PSPF-EKG eluted with an apparent molecular weight 6.5-fold higher than the
calculated molecular weight at pH 7.4 and 5.2-fold at pH 5.5 (Figure 4.4, Table 4.5), both
as a single species. Noticeably PSPF-EKG presented a peak with significantly lower
intensity and a broad trailing feature when eluting at pH 5.5, indicating that the decreased
pH has increased the propensity to interact with column, which may act as a mimic of the
membrane phase (Figure 4.4A). Dissociation during elution might also contribute to the
peak shape, indicative of a lower stability of the water-soluble helical bundle. Similarly,
PSPF-DKG eluted with an apparent molecular weight 6.0-fold higher than the calculated
molecular weight at pH 7.4 as a single species and nearly failed to elute at pH5.5 (Figure
4.4A), indicating the lower pH drove the peptide to interact with the column. Furthermore,
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the salt concentration has been increased to 2M and the shoulder of elution peak for
PSPF-EKG still exists at pH 5.5 (Figure 4.4C, D). Also, Asp at the putative a position
makes the PSPF-DKG more sensitive to the pH decrease than Glu in PSPF-EKG, in term
of driving the peptide‟s preference away from the aqueous phase (Figure 4.4A).

Figure 4.4 Size exclusion chromatography of PSPF-EKG and PSPF-DKG at each pH.
Both PSPF-EKG and PSPF-DKG elute as a single species corresponding to the
oligomerization of hexamer at pH 7.4 (B). PSPF-EKG elutes as a single-species peak
with a significant shoulder at pH5.4 and the major peak corresponds to a formation of
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hexamer. PSPF-DKG almost fails to elute at PH 5.5 (A). The salt concentration has been
increased to 2M and the shoulder of elution peak still exists at pH 5.5 (C, D).

Table 4.5 Apparent molecular weight and calculated oligomerization state based on size
exclusion chromatography for PSPF- EKG and PSPF- DKG at both PHs
PSPF-EKG
pH 7.4
pH 5.5
Apparent MW
19,000
15,000#
Oligomerization State*
6.6
5.2
* Oligomerization State = Apparent MW/ Monomer MW
#
Major peak

PSPF-DKG
pH 7.4
pH 5.5
17,000
N/A
6.0
N/A

Sedimentation equilibrium of analytical ultracentrifugation
Analytical ultracentrifugation (AUC) sedimentation equilibrium46, 53 was applied
to further investigate the association state and affinity of the water-soluble bundles of
both PSPF- EKG and PSPF- DKG. The peptides were studied at 100 μM peptide
concentration and pH 7.4 (150 mM NaCl, 50 mM Tris) or pH 5.5 (150 mM NaCl, 50 mM
MES). The parameters were globally fit to data collected over multiple rotor speeds (35,
40, 45, 50 KRPM). Fitting the curve to a single MW species suggested an apparent
molecular weights for PSPF- EKG of 18,000±30 at pH 7.4 (Figure 4.5A) and 16,000±30
at pH 5.5 (Figure 4.5B). This agrees well with the data from size exclusion
chromatography and points to a hexameric association state at both pHs for PSPF-EKG.
The data can be further fit to a monomer-hexamer equilibrium, resulting in an association
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energy ΔG of -6.3 kcal/mol monomer at pH 7.4 and -5.6 kcal/mol monomer at pH 5.5
(Table 4.2). Also, as shown in the plot of species weight fraction, the concentration of
peptide required to associate at pH 7.4 was lower than at pH 5.5 (Figure 4.5B, D).
Together it suggests that decreased pH destabilized the helix bundle of PSPF- EKG.

Figure 4.5 AUC sedimentation equilibrium of PSPF-EKG at pH 5.5 (A) and 7.4 (C).
Single species fitting of PSPF-EKG suggests a hexameric association state at both pH 7.4
(A) and pH 5.5 (C). For each peptide and pH condition, the top plot shows the single
species fitting with residuals above while the below plot shows the species weight
fraction. Then the data has been fit with a monomer-hexamer equilibrium model at both
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pHs. The dissociation state and dissociation energy is shown in Table 4.6. The weight
fraction distributions have also been plot for pH 5.5 (B) and pH 7.4 (D).

For PSPF-DKG, a global fit resulted in a single-species apparent molecular
weight of 17,000±30 at pH 7.4 (Figure 4.6A), which was 6.0-fold higher than the
calculated molecular weight and again agrees well with size exclusion chromatography.
The equilibrium of PSPF-DKG has also been fit into the equilibrium of monomerhexamer with association energy ΔG of -6.5 kcal/mol monomer (Table 4.6). The singlespecies apparent molecular weight for PSPF- DKG at pH 5.5 was 24,000±60 (Figure
4.6B). This could represent a heterogeneous set of association states, taken together with
the broad elution peak observed in the size exclusion chromatography.

Figure 4.6 AUC sedimentation equilibrium of PSPF-DKG at pH 5.5 and 7.4. Single
species fitting of PSPF-DKG suggests it associates as a hexamer at pH 7.4 and reaches an
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apparent molecular weight of approximately 24,000 at pH 5.5. For each peptide and pH
condition, the top plot shows the single species fitting with residuals above while the
below plot shows the species weight fraction.

Table 4.6 Analytical ultracentrifugation (AUC) sedimentation equilibrium for PSPF-EKG
and PSPF- DKG at pH 5.5 and 7.4.

PSPF-EKG

PSPF-DKG

pH 7.4

pH 5.5

pH 7.4

pH 5.5

Apparent MW

18,000±30

16,000±30

17,000±30

24,000±60

Oligomerization State*

6.2

5.5

6.0

N/A

-log(Kdissociation)

28.0±0.4

24.8±0.1

28.7±0.4

N/A

Association ΔG#
(kCal/mol monomer)

-6.3

-5.6

-6.5

N/A

* Oligomerization State = Apparent MW/ monomer MW
#

Association ΔG = 2.303*RT* log(Kdissociation)/6

Circular dichroism and thermal denaturing
Circular dichrosim (CD) suggests that PSPF-KEG adopts an alpha-helical
secondary structure at both pHs (Figure 4.7).
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Figure 4.7 Circular dichroism of PSPF-EKG suggests an alpha-helical secondary
structure at both pHs.

Furthermore, thermal denaturation by circular dichroism (CD)199 was used to
study the thermal stability of the PSPF- EKG hexamer at multiple concentrations (2μM, 4
μM and 20 μM), and at both pH 7.4 (Figure 4.8A) and pH 5.5 (Figure 4.8B). For each pH,
to the curves were analyzed according to the Gibbs-Helmholtz Equation, using global
least squares fitting of ΔHm, Tm and baselines. Tm was chosen as a global parameter
defined with a reference concentration of 4 μM. ΔCp was also included, but over the
range of experimental data examed, this parameter was not well defined.

Gibbs-Helmholtz Equation: ΔG=ΔHm(1-T/Tm)-ΔCp[Tm-T+T[ln(T/Tm)]]
Here ΔG refers to the unfolding energy upon thermal denaturation, T refers to
temperature, Tm refers to the melting temperature at which ΔG equals to zero. ΔHm refers
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to the enthalpy at Tm, and ΔCp refers to the change in the heat capacity over the
temperature range.

Figure 4.8 Thermal denaturation of PSPF- EKG at pH 7.4 (A) and 5.5 (B). The data are
fit to the Gibbs-Helmholtz Equation.

The enthalpy at pH 7.4 is 22.0 kcal/mol monomer and is approximately 12%
higher than at pH 5.5 (19.6 kcal/mol monomer) (Table 4.7). The value of enthalpy at both
pHs are typical for designed water-soluble helix bundles.200 The melting temperature Tm
is 339.0 K at pH 7.4 and is 5.6 K higher than at pH 5.5 (333.4K). The concentration of
PSPF-EKG required to have 50% of the total amount of peptide remain folded at 300K
was calculated to be 0.31μM at pH 5.5, which was approximately double the
concentration of peptide required for 50% folding at pH 7.4 (0.14μM). These data suggest
that decrease in pH destabilizes the folding of PSPF-EKG.
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Table 4.7 Fitting results for CD thermal denaturation of PSPF- EKG at both pH 7.4 and
pH 5.5

pH

ΔH (kcal/mol monomer)

Tm (K)

[ PSPF-EKG ] at 50% fold and 300K

7.4

22.0±0.1

339.0±0.1

0.14μM

5.5

19.6±0.1

333.4±0.1

0.31μM

113

The structural properties of PSPF- peptides in a membrane micelle system
Sedimentation equilibrium of analytical ultracentrifugation
AUC sedimentation equilibrium of PSPF-EKG in detergent micelles pointed to a
weak oligomerization at both pHs. PSPF-EKG was dissolved in N-tetradecyl-N,N
dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine) micelles. The density of the
solution was adjusted by D2O to precisely match that of the C-14 betaine detergent at
both pH 7.4 and pH 5.5 (50 mM sodium phosphate and 150 mM NaCl), so that only the
peptide component contributes to the sedimentation equilibrium.60, 139

Three samples prepared at different peptide-to-detergent ratios (1:50, 1:100,
1:200) were each centrifuged at four rotor speeds (35, 40, 45, 50 KMRP) at each pH. The
data could be fit into a monomer-trimer, monomer-tetramer, and monomer-higher
oligomer equilibrium, suggesting that PSPF-EKG weakly associates in detergent micelle.
Figure 4.9 showed an example in which a monomer-trimer equilibrium is fit to the data at
pH 7.4 (Figure 4.9A) and pH 5.4 (Figure 4.9C), and the weight fraction distribution has
been shown in Figure 4.9B and 4.9D.
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Figure 4.9 The single-species fitting of AUC sedimentation in detergent micelles for
PSPF-EKG at pH 7.4 (A) and 5.5 (C). Species weight fraction of PSPF- EKG at pH 7.4
(C) and pH 5.5 (D) as the data were globally fit to a monomer-trimer equilibrium as an
example.
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The Orientation of PSPF- EKG in a Lipid Bilayer
Attenuated total reflection IR spectroscopy
The secondary structure and orientation of PSPF-EKG in deuterium oxide (D2O)
hydrated bilayers were evaluated using attenuated total reflection IR spectroscopy (ATRIR).143, 144, 201 The IR spectra in the amide I region of the PSPF-EKG showed a single
peak at 1656 cm-1, indicative of a dehydrated helical conformation in bilayers (Figure
4.10). The dichroic ratio for parallel versus perpendicularly polarized light was 1.5. This
order parameter would correspond to an orientation of approximately 75° relative to the
membrane normal, assuming the bilayers are well ordered and the entire peptide is fully
helical. The result suggests that the majority of peptide lies parallel to the lipid surface,
and rules out the possibility of the peptide being oriented predominantly perpendicular to
the bilayer surface. The fact that the computed angle is less than 90° is also consistent
with a small amount of peptide adopting a vertically inserted conformation, in
equilibrium with the predominant form, although other models could also lead to the
observed 75° angle.
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Figure 4.10 ATR-IR of PSPF-EKG in phospholipids (POPC) bilayers. The peak at 1656
cm-1 is indicative of alpha helical secondary structure. The orientation is demonstrated by
the ratio of peak area of the 1656 cm-1 amide I bond for parallel (0°) versus perpendicular
(90°) polarized incident light (relative to the membrane normal).
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4.4

Conclusion and Discussion
Therapeutic macromolecules such as peptides and proteins are easily cleared from

the bloodstream and require assistance for intracellular delivery in order to reach their
intended targets and achieve the desirable therapeutic effects. Decades of research effort
have been devoted to develop delivery agents with high efficiency and low toxicity.

202,

203

Viral vectors are considered to be successful delivery agents and have been
extensively studied for gene therapy. Viral vector based gene therapy has demonstrated
promising results,101 but this potential life-saving delivery technique can also be risky.
The death of a patient in the Paris trial suggests that viral vectors might also induce
undesirable gene insertion and this potential danger is currently uncontrollable. 204, 205

Most non-viral carriers are synthetic chemical conjugates. Active ingredients
(drugs) are usually linked or enclosed into a vehicle and delivered into the cell via
endocytosis or membrane fusion, or via a yet to be determined mechanism.206, 207 These
vehicles are typically designed as liposomes/lipoplexes,208 cationic macromolecules
polymer,209

polypeptide,210

nanoparticles213-215

and

protein,211

amphiphilic

polymer/polypeptide,212

and cell penetrated peptides (CPP).83 Native sequences such as

fusogenic peptide from viral fusion protein216 have also been manipulated as a cargo
carrier to cross the barrier of cell membranes. A number of these approaches have also
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entered clinical trials, but most of them reached a bottleneck due to high toxicity or lack
of manipulability. 207

Here, we have designed a series of pH-switchable peptides as potential candidates
for intracellular (lysosomal) drug delivery. One of the top candidates, PSPF-EKG, has
stood out from RBC lysis assay, in terms of highest target molecule delivery efficiency at
selective pH (5.4). Lack of hemolytic activity ruled out the possibility of undesirable
membrane description by PSPF-EKG at both pHs. Also, the nice correlation between
ATP release at pH 5.5 and Trp-fluorescence at pH 5.4 upon lipid titration (Figure 4.3),
indicates that membrane insertion presumably plays a key role in ATP release.

RBC Lysis data also provide a direct comparison among all the designed peptides.
Firstly, we have three options of pH-trigger residues in this peptide series. Asp and Glu
residues both presented expected pH-switchable ATP and miRNA release in peptides
PSPF-DQA and PSPF-DKG, indicating the carboxyl side chain groups respond
efficiently to environmental pH change, though their intrinsic pKa of the unperturbed
sidechain is around 4. The third trigger candidate, His, failed to show significant pH
preferences in terms of ATP or miRNA release. However PSPF-HKG induced high ATP
release percentage at both pHs. Presumably His will induce pore formation in a pHindependent manner. Nevertheless, all the His variants ran into solubility issues in the
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further biophysical characterization and thus are not considered as preferred candidates
for further pharmaceutical development.

Secondly, Lys and Gln have been chosen in f positions in order to provide helix
propensities in aqueous system and solvent exposure surface in membrane system. The
RBC lysis results did not discriminate between these two residues when comparing the
performance of the aspartate and glutamate peptide variants (PSPF-EKG versus PSPFEQG, PSPF-EKA versus PSPF-EQA).

The third screened parameter is the choice between Ala or Gly for residues
packed in the helix interface. This part of the design was in light of previously discovered
fact that small residues were preferred in TM helix interaction interface to stabilize the
final folded state (TM helix bundle).75, 139 In the case of PSPF-EKG versus PSPF-EKA,
Gly resulted in a much higher pH–switchable ATP and miRNA release. The results agree
with the previous conclusion that Gly in TM helical interface drives stronger TM helix
association that Ala,139 presumably because Gly stabilizes the helix interaction via weak
Cα-H interaction.217

A variety of biophysical assays have been applied in order to obtain a
comprehensive mechanism of PSPF-EKG‟s pH switchable pore formation. We first
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looked at the structural conformation and folding stability of PSPF-EKG in aqueous
solution. CD, AUC and SEC suggest that PSPF-EKG forms a stable helix bundle at both
pHs (Figure 4.11A), which is expected due to the designed canonical Leu-zipper coiledcoil motif. AUC and thermal denaturing have been further used to study the folding
stability difference between pH 7.4 and pH 5.5. The free energy of helix bundle has
increased by 0.7 kcal/mol monomer upon pH decrease. Both ΔCp and Tm decrease at pH
5.5 versus pH 7.4, suggesting that PSPF-EKG is better packed in higher pH. Also, in SEC
PSPF-EKG presented a significant shoulder upon elution at pH 5.5 versus a sharp peak at
pH 7.4. The shoulder did not disappear even as the salt concentration in buffer increased
from 150 mM to 2 M. The data suggest pH decrease destabilizes the stability of PSPFEKG in aqueous system (Figure 4.11A, B), thus validating the first consideration of the
original design.

We characterized PSPF-EKG in micelles and bilayers. Equilibrium sedimentation
AUC suggests PSPF-EKG adopts a monomer-oligomer equilibrium in C14-betaine
micelles at both PHs (Figure 4.11C, D), with slightly higher stability at pH 5.5 than at pH
7.4 (Figure 4.9B, D). A unique oligomerization state could not be determined by AUC
due to weak association. Furthermore, the orientation of PSPF-EKG has been studied by
ATR-FTIR in POPC lipid bilayers. The average dichroic angle is about 75 degrees with
respect to the lipid normal, revealing that the majority of peptides are in a membranesurface-absorbed state and adopt a vertical conformation with respect to the lipid normal.
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This state presumably corresponds to the monomer state identified by AUC (Figure
4.11C). Also, some of the peptides adopt a TM orientation, which might reflect a weakly
associated oligomeric form (Figure 4.11D). This dynamic equilibrium between vertical
monomer in membrane-surface-absorbed state and TM oligomer state, presumably
induces membrane pore formation and plays a crucial role in ATP and miRNA release
(Figure 4.11D).

Figure 4.11 Model of PSPF-EKG membrane insertion and pore formation upon pH
decrease.

All the biophysical characterizations have corroborated a model for the
mechanism of pH-controllable pore formation and ATP/miRNA release (Figure 4.11).
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The primary future direction for enhancing the designs is to increase the population of
TM peptide relative to the surface-absorbed state. There are two possible avenues that we
will pursue towards this aim. Firstly, the inter-peptide interactions in the TM state will
be strengthened to favor oligomerization. Secondly, the energetic cost of insertion into
the bilayer will be decreased by modifying the hydrophobicity of these peptides.
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4.5 Methods
Hemolysis assay
Hemoglobin
Human Red Blood hemolysis assay was by carried out as described elsewhere218
with modifications: 5 ml human blood from healthy individuals were transferred into a 50
ml centrifuge tube and either resuspended in 35 ml buffer pH 5.4 (150 mM NaCl, 20 mM
MES) or pH 7.5 (150 mM NaCl, 20 mM Hepes). Red Blood Cells (RBCs) were washed 3
times with the appropriate buffer and finally resuspended in a total of 50 ml buffer (pH
5.4 or 7.5). For the assay 175 μl of buffer solution (pH 5.4 or 7.5) was added into each
well of a clear-bottom 96-well plate followed by 50 μl of resuspended RBCs (approx.
2.5x107 cells) in the appropriate buffer (for RBC transfer wide bore pipet tips were used
to avoid cell damage). Test PSPF peptides (New England Peptide

TM

) at the appropriate

concentration were diluted in 25 μl PBS and then added to the cells. All steps were done
with chilled buffers and on ice. The suspension was then mixed 6-8 times by pipetting
with wide bore tips, the plate was covered and incubated at 37°C for indicated time. After
incubation the cells were centrifuged for 5 min at 500 x g and 150 μl of the supernatant
was transferred into a new 96-well clear-bottom plate. Absorbance at 541 nm was
measured and hemolysis was normalized to RBCs which have been incubated in the
presence of 1 % Triton X-100 (100 % hemolysis).

Micro-RNA mir-16
The release of micro-RNA mir-16 from RBCs was determined using stem-loop
PCR as described elsewhere 219. Briefly, 5 μl of supernatant was processed with TaqMan
MicroRNA Cells-to-CT Kit (Applied Biosystems) according to manufacturers' protocol
and quantitative PCR reaction was performed on an ABI (Applied Biosystems) 7500 Fast
Real Time PCR System using standard cycling conditions

220

. The derived Ct values for
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mir-16 (Applied Biosystems cat. no.: 4373121) in each experiment were transformed into
copy numbers using a linear equation derived from a standard curve which was run in
parallel.

ATP
To quantitatively determine the amount of Adenosine TriPhosphate (ATP) in the
supernatant, the ATPLite assay kit (Perkin Elmer; Waltham, MA) was used according to
the manufacturers' instructions using 100 μl supernatant per reaction point.

Tryptophan fluorescence excitation wavelength
The fluorescence spectra were collected on a Fluorolog spectrofluorometer. The
tryptophan fluorescence of each peptide was measured at both pH5.5 and pH7.4 (30m M
Phos and 150m M NaCl ), with and without lipid titration.221 The lipid stock was
prepared with 90% POPC and 10% POPG, and the final concentration of lipid after
titration is 200μM. The peptide concentration in each measurement was 2μM.

CD measurement and thermal denaturation
CD spectra were collected with a Jasco J-810 spectropolarimeter using a 1-nm
step at 4 °C, at both pH5.5 and pH7.4 (30m M Phos and 150m M NaCl ).139 The PSPFEKG peptide concentration was 2 μM. The CD spectrum was obtained by averaging over
three scans.
125

The helical CD signal at 222nm for 2μM, 4μM and 20μM was monitored as
temperature increased from 4 °C to 96 °C at both pH5.5 and pH7.4 (30m M Phos and
150m M NaCl ) , in a 2 °C steps.46 The parameters from the Gibbs-Helmholtz Equation
were fit to the data as shown in Result 3.4.4.3. The fitting was demonstrated in the
previous publication.200

Size exclusion chromatography
Size exclusion chromatography (SEC) of 100μM PSPF-EKG and 100μM PSPFDKG were measured by AKTA FPLC machine (GE) using a Superdex 75 column (GE)
eluted at pH 7.4 (50 mM Tris, 150 mM NaCl) and pH 5.5 (50 mM MES, 150 mM NaCl)
respectively, at 25°C.46 Four standards were used: blue dextran (2,000,000 g/mol),
carbonic anhydrase (29,000 g/mol), cytochrome C (12,400 g/mol) and aprotinin
(6,500g/mol). In order to test the effect of salt concentration upon peptide elution, the
elutions of PSPF-EKG were also measured at pH 7.4 (50 mM Tris, 2M NaCl) and pH 5.5
(50 mM MES, 2 NaCl), respectively.

Sedimentation Equilibrium of Analytical Ultracentrifugation (AUC)
Sedimentation Equilibrium of Analytical Ultracentrifugation (AUC) of 100μM
PSPF-EKG was measured at 25 °C using a Beckman XL-I analytical ultracentrifuge at 35,
40, 45, and 50 kRPM, at both pH 7.4 (50 mM Tris, 150 mM NaCl) and pH 5.5 (50 mM
MES, 150 mM NaCl). The data was globally fit to a nonlinear least squares curves by
IGOR Pro (Wave-metrics) as previously demonstrated. 82, 139, 141, 157
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The AUC measurement of PSPF-EKG has also been measured in N-tetradecylN,N dimethyl-3-ammonio-1-propanesulfonate (C-14 betaine) micelles. 17% D2O in
buffer was used to precisely match the density of 8mM C-14 betaine micelle at pH 7.4
(50 mM Phos, 150 mM NaCl) and 22% D2O was used for pH 5.5 (50 mM Phos, 150 mM
NaCl). Three groups of samples were prepared as peptide:DPC molar ratios of 1:50,
1:100, and 1:200 at both pHs. The data with three peptide/detergent ratios and four rotor
speeds (35, 40, 45, and 50 kRPM) was globally fit to to a nonlinear least squares curves
by IGOR Pro (Wave-metrics) as previously demonstrated. 82, 139, 141, 157

Attenuated Total Reflection IR Spectroscopy (ATR-IR)
ATR-IR of PSPF-EKG was measured by a Nicolet Magna IR 4700 spectrometer
using 1 cm−1 resolution.143, 144, 201 5.0-7 mole PSPF-EKG in trifluoroethanol (TFE) was
mixed with 20 fold mole of 1-palmitoyl-2-oleoyl-snglycero-3-phosphocholine (POPC)
and dried into a thin film on the surface of ATR Ge crystal evenly by N2 gas. The film
was rehydrated by D2O-saturated air overnight in closed environment of D2O bath.
During data acquisition, the polarized mirror was adjusted to 0° and 90°, creating incident
light oriented parallel and perpendicular to the lipid normal respectively. The infrared
spectrum of each condition was averaged over 256 scans. The dichroic ratio of 1656 cm−1
amide I bond absorption is computed for parallel (0°) versus perpendicular (90°)
polarized incident light relative to the membrane normal and has been used to calculate
the peptide orientation as previously shown. 143
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4.6

Contributions:
William F DeGrado, Gevorg Grigoryan, Michael Bryan, Jason Donald and Yao

Zhang developed the design principles; Rene Bartz, Stephen C. Beck, Nathalie Innocent,
David Tellers and Vasant Jadhav from Merck. & Co. performed the cellular release
assays; Michael Bryan performed Trp fluorescence, CD scan, and thermal denaturing
assays, Yao Zhang performed thermal denaturing data analysis, SEC, AUC, ATR-FTIR
and the related data analysis.
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5 Chapter 5: The design and characterization of a membrane
metalloprotein

5.1

Introduction
Despite the significant progress in understanding membrane protein folding,14, 59,

82, 139, 157

the rational design of membrane proteins still remains challenging. Previous

efforts have demonstrated successful examples of water-soluble metalloprotein design.222225

Also, the design has been further applied to ferrous-ferric redox chemistry as a protein

scaffold and exhibited enzymatic functions.226 Similar metal-binding properties in the
membrane phase have long been desired in order to design novel membrane biomaterials
and advance our understanding of membrane protein folding.157

Here, we present a designed membrane di-iron binding protein MDF (Membrane
Duo Ferro). This membrane protein binds to two ferrous cations within a single site and
forms a ferrous complex which can then be oxidized into a diferric species upon air
oxidation. The design will contributes to our understanding of membrane protein folding.
and provides groundwork for designing metalloenzyme that can catalyze the oxidation of
small molecules in the membrane phase
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5.2

Results
The design rational focuses on three major design decisions. Firstly, a His/Glu

chelation system was chosen as the metal-binding center, because it is commonly
observed in natural and previously designed systems (Figure 5.1A, Table 5.1).222, 223, 225,
227-229

Secondly, a four-helix bundle, which has been proven successful in natural and

previously designed water-soluble metalloproteins,223, 225,

227, 228, 230

was chosen as the

minimal catalysis scaffold for the metal binding site (Figure 5.1B), In contrast to the
heterotetramer scaffold which is abundant in designed water-soluble metalloproteins
(some were designed as a single chain linked by loops),224-226 the design of our membrane
metalloprotein starts with a homotetramer template in order to simply the system. Each
monomer helix contains both His and Glu residues in order to provide the necessary
chelating side-chains. Thirdly, the majority of the backbone sequence was adopted from a
previously successfully designed and characterized transmembrane model helix MS1
(Table 5.1),60 to sidestep any complications with protein aggregation which has been
observed in previously computationally designed membrane proteins in house. Based on
these criteria the sequence of MDF has been generated as shown in Table 5.1.
Table 5.1 The sequences of DFtetB, MS1 and MDF
.
Peptide
g abcdefg abcdefg abcdefg abcdefg
E LEELESE LEKILED EERHIEW LEKLEAK LEKL
DFtetB*
MS1
BQLLIA VLLLIAV NLILLIA VARLRYL VG
KKW LLLLIAS ELIHLIL LALLRYL VG
MDF
*DFtetB is one chain of a designed water-soluble metal-binding heterotetramer.226 The
chelating residues (Glu and His) have been highlighted in red
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Figure 5.1 Frequently observed His/Glu chelated metal system in both natural and
designed proteins230 (A). Four-helix bundle scaffold for MDF (B).

Designed as a membrane helix, MDF is insoluble in water but can be dissolved
and studied in dodecylphosphocholine (DPC) detergent micelles, which mimic the
membrane system. A variety of biophysical characterizations have been applied to MDF
in order to understand its folding properties. The secondary structure of the apo form
studied by circular dichroism (CD), suggests that MDF adopts an alpha-helical secondary
structure in micelles at pH7.4 (buffer condition, same buffer in the following assays)
(Figure 5.2A). Analytical ultracentrifugation (AUC) sedimentation was also applied to
study the association state of MDF at pH7.4. The density of the solution was adjusted by
D2O to precisely match that of the DPC detergent such that the sedimentation equilibrium
was only contributed by MDF peptide component. Fitting the curve to a single molecular
weight (MW) species fitting suggests an apparent MW for MDF of 12,500±50 (Figure
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5.3A), indicating that a tetramer is formed by the MDF helices. Therefore MDF selfassembles into a membrane four-helix bundle in detergent micelles.

Figure 5.2 CD spectra of MDF (A) and iron-bound MDF (B) in DPC micelles. The
spectra show that both apo and bound forms are predominantly α-helical at a
peptide:DPC ratio of 1:25.

Figure 5.3 Sedimentation equilibrium analysis of MDF (A) and Co(II)-bound MDF (B).
in DPC micelles. The absorbance was measured at 300 nm. The single-species fitting
sugeests a tetramer conformation for both apo and bound forms The Top of each panel
shows the residuals of the fit.
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Co(II) is extremely sensitive to its environment, and therefore the UV–visible
spectrum can provide useful information on the stoichiometry of metal-binding and the
metal-coordination environment.225 The molar extinction coefficient of Co(II) increases
as the coordination number decreases. As Co(II) was titrated into MDF, three absorption
bands with λmax 530nm, 550nm and 600nm were observed (Figure 5.4A), presumably due
to the cobalt ion‟s d–d transitions after coordination by the sidechains of MDF. The
extinction coefficient at 550nm was calculated to be 460 M−1 cm−1 and is indicative of a
hexacoordinate Co(II) complex within MDF.225, 231 Furthermore, a series of concentration
of Co(II) was titrated to MDF and the absorbance at 550nm was plot as a function of
Co(II)/MDF molar ratios (Figure 5.4B). The data fits nicely with an equilibrium model of
two eqivalent Co(II)s binding to one MDF tetramer(Scheme 1), resulting in –log (Kd) of
14.0. Equilibria with other binding stoichiometries have also been applied, yielding
significantly poorer fitting quality.

Figure 5.4 (A) Co(II) spectrum of MDF, (B) Titration of MDF with Co(II)
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Scheme 1.
Tetramer 2 Co(II)  Tetramer 2 Co(II)

Kd 

[Tetramer 2 Co(II)]
[Tetramer][Co(II)]2

The association state of MDF●2Co(II) complex, where Co(II) and MDF tetramer
are mixed at stoichiometric ratio (2:1), has also been measured by AUC sedimentation.
The single-species fitting indicates an apparent MW of 11,700±50 (Figure 5.3B).
Therefore the metal-bound form remains tetrameric. Moreover, CD spectra of addition of
Fe(II) into MDF tetramer at stoichiometry ratio (2:1) suggested an alpha-helical
secondary structure (Figure 5.2B), indicating that Fe(II)-binding does not affect the
secondary structure of MDF. Therefore the metal-bound form also adopts a four-helix
bundle conformation.

Finally Fe(II) has been used as a spectroscopic probe to study the kinetics of
metal binding.224, 226 Since the ferrous form is rapidly oxidized into ferric form in the
presence of ambient O2, the kinetics of diferric oxo-bridged species formation could be
considered as the kinetics of the metal binding step. The time course of the absorbance of
MDF tetramer upon the addition of 2 equivalents of Fe (II) was measured by UV-vis
spectroscopy. The intensity increase at 320 nm, which results from the ligand-to-metal
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charge transfer of the diferric oxo-bridged species, was collected.224, 226 The curve of the
intensity increase at 320 nm as a function of time was fitted with the equilibrium in
scheme 2 and resulted in a metal-binding rate of 1.6s-1; about 60 fold faster than the rate
observed in the water-soluble metalloprotein (1.5min-1).

Scheme 2.
Slow)
2 ( Fast )
2Fe( II )  Tetramer (
Tetramer  2Fe( II ) O

Tetramer  2Fe( III )

Figure 5.5 (A) Oxidation of Fe (II) in presence of MDF, (B) The time course of the
intensity increase at 320nm was fit based on Scheme 2.
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5.3

Conclusion and discussion
In conclusion, we have successfully designed a membrane four-helix bundle,

which tightly binds metals at a 2 metal cation: 1 tetramer stoichiometric ratio. Since MDF
binds to iron cations, it allows the possibility of introducing iron-based redox reaction
centers in the membrane phase and can serve as a template for further membrane
metalloenzyme design.
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5.4 Methods
Peptide Synthesis, cleavage and purification
The sequence of MDF is KKWLLLLIASELIHLILLALLRYLVG. The peptide
was synthesized at a 0.1 mmole scale on RINK amide resin (Novabiochem) on a
Symphony peptide synthesizer as previously described139. The resin is further cleaved in
a mixture of trifluoroacetic acid (TFA)/water/triisopropylsilane (94/3/3) and precipitated
with cold diethyl ether. The crude product is purified using a reverse phase HPLC (Vydac,
C4 Column) in a gradient of solvent A (water with 0.1% TFA) and solvent B (60%
isopropanol, 30% acetonitrile, 10% water and 0.1% TFA).

Circular dichroism (CD)
In order to prepare peptide detergent micelles, MDF and DPC were mixed in
2,2,2-trifluoroethanol (TFE), dried under nitrogen and rehydrated with the experimental
buffer. CD measurements of MDF were carried out in 80μM MDF and 2mM DPC at pH
7.4 (10mM MOP and 10mM NaCl). The measurement of iron-bound form was acquired
in a 0.1 cm quartz cell with a Jasco J-810 CD spectropolarimeter, using a 1-nm step at
25°C.The final CD spectra of MDF were averaged over three scans and the baseline
(obtained by DPC in buffer) was subtracted. The CD spectra of the iron-bound form were
collected from a sample containing 40μM iron cation, 80μM MDF and 2mM DPC, the
mixture of which has been incubated for 12 hours prior to measurement.
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Analytical ultracentrifugation (AUC)
Sedimentation equilibrium experiments and data analysis were processed as
previously demonstrated.82, 139, 141, 157 The samples contained 320 μM and 160 μM MDF
respectively in 8mM DPC at pH7.4 (100mM HEPES and 100 mM NaCl). 37% D2O has
been included in order to match the density of the detergent. The experiments were
conducted at 25 °C using a Beckman XL-I analytical ultracentrifuge at respectively 30,
35, 40, 48 KRPM. Data obtained were globally fitted to a nonlinear least-squares curve
by IGOR Pro (Wavemetrics).

Co (II) titration
The spectra of Co(II) absorption were collected from 200μM MDF and 5mM
DPC at pH7.4 (150mM MOP and 150 mM NaCl), using a Cary 300 UV spectrometer.
CoCl2 was added to the sample and allowed to equilibrate at room temperature. Data
obtained were fitted to scheme xx by IGOR Pro (Wavemetrics).

Fe (II) binding kinetics
The kinetics of Fe (II) binding was measured at 100μM MDF and 2.5mM DPC at
pH7.4 (150mM MOP and 150 mM NaCl), using a Hewlett Packard model 8453 diode
array spectrometer. The reaction was initiated by addition of Fe(II) from a stock solution
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(10mM Fe(NH4)2SO4 and 0.01%H2SO4), reaching a final concentration of 50μM Fe(II).
Data obtained were fit to scheme xx by IGOR Pro (Wavemetrics).

5.5

Contributions
William F. DeGrado and Yao Zhang designed MDF. Yao Zhang performed all the

experiments and related analysis in this chapter.
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6 Chapter 6:Conclusions and Discussions

This thesis has used helix association as a model system and contributed to our
knowledge in: 1. identifying the role of membrane protein folding in type I envelope viral
fusion; 2. understanding the driving forces behind membrane protein folding; 3.
designing and characterizing novel therapeutic agents.

Chapter 2 introduces the importance of membrane protein folding in viral fusion,
where I have discovered that the N-terminal hydrophobic fusion peptides of
paramyxovirus fusion proteins form a six-helical TM bundle. This is the first
experimental evidence that suggests the fusion peptide of type I viral fusion protein
adopts a transmemrbane alpha helix secondary structure in lipid bilayers.

Further

experiments show that the C-terminal membrane segment of the fusion protein strongly
interacts with the corresponding N-terminal fusion peptide in a 1:1 ratio. All the data
point to a cooperative folding of fusion proteins in both the membrane, in addition to the
previous discovery about folding in the water-soluble regions, which is predicted to play
a critical role in overcoming the energy barrier of lipid mixing between virus and host
cell and driving viral fusion. Based on this discovery, we proposed a novel proteinfolding-centric viral fusion model.
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In Chapter 3, using a de novo designed membrane model peptide MS1, I have
identified some of the key forces that drive membrane helix association in chapter 5. My
experimental data demonstrated that as the size of apolar residue in the putative a
position decreases (from isoleucine, to valine, to alaline, to glycine), the helix association
affinity significantly increases, the trend of which is opposite to that in aqueous systems,
in which hydrophobic interaction is the driving force for folding. Instead, van der Waals
interaction appear to plays the crucial roles in bringing membrane helices together and
small apolar residues are preferred at the helix interface. Moreover, apolar residues in the
helix interfaces also determine the orientation of helix-helix interaction. As the apolar
residues in the interface get smaller, the helices are able to get closer to each other, and
the role of electrostatic interaction is significantly increased. In order to satisfy the
dipole-dipole interaction between the backbones and stabilize the helix bundle, an antiparallel orientation is preferred. This is the first time that role of these two driving forces
have been experimentally identified in membrane helix interactions.

In light of the discovery in Chapter 3, we have designed a group of pH-switchable
helix-association-based intracellular delivery agents in Chapter 4. This design has
touched a few challenging points: 1. The designed peptide forms stable water-soluble
helix in water-soluble system at pH7.4; 2. As the pH decreases to 5.5, which corresponds
to the pH in endosome, the stability of water-soluble form was destabilized and the
peptide is driven to the membrane insertion; 3. The peptide is also designed to form
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stable TM helix bundle at pH 5.5 and lead to endosomal release. The first round of design
chose Glu, Asp and His as the pH-dependent switch trigger. Leucine zipper has been
selected to stabilize water-soluble form. Small residues such as Gly and Als have been
used to stabilize TM helical interface, based on the results from Chapter 3. Furthermore,
Lys and Arg have been screened to be water-exposure phase in both water-soluble system
(outer-surface) and membrane system (the interior of channel). The top candidate PSPFEKG in the first round design has successfully induced ATP and miRNA release upon pH
switch. Results from the following biophysical assays also point to a mechanism model
that agrees well with the original design.

Furthermore, the design and characterization of a membrane metalloprotein has
been demonstrated in Chapter 5. This design took the self-assembly of a membrane fourhelix bundle as scaffold and introduced the metal binding (Co2+ and Fe2+) via Glu and His
chelating. The design has been validated and can serve as a scaffold for future membrane
metalloenzyme design.

In summation, this thesis covers a wide array of diverse applications related to the
helix-association model, from the mechanism identification of diseases systems, to the
fundamental study of protein folding, and finally to the design of novel functions. The
work presented here has contributed to our understanding of protein folding and explored
the application of protein folding, in both aqueous and membrane system.
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